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1. Abstract 
 
SNARE (soluble NSF attachment protein receptor) proteins comprise distinct families 
of proteins conserved from yeast to human, which are essential for membrane fusion 
in cellular processes like vesicle trafficking, neurotransmitter release or yeast 
vacuole fusion. Prior to membrane fusion, SNARE assemble to form a stable 
complex, that according to the “zipper” model starts from the cytosolic domain and is 
propagated to the transmembrane domain (TMD). Previous evidence indicated that 
the TMD of SNARE proteins has not only the role of anchoring the protein to the 
membrane but is important for the function. In this work, I investigated the role of 
TMD in assembly of the neuronal SNARE synaptobrevin II and of the yeast vacuolar 
SNAREs. 
Homodimerization of the neuronal SNARE synaptobrevin II, involved in the 
neurotransmitter release, previously was shown by different authors to depend on its 
TMD. Here synaptobrevin II Homodimerization was shown to be preserved better in 
the presence of urea than in its absence. At the same time, urea is not affecting α-
helical structure of its TMD as detected by CD measurement. 
The role of TMD in yeast vacuolar SNARE protein assembly is here characterized 
under native conditions. Sucrose gradients showed that the vacuolar SNARE Vam3p 
forms a homodimer that is clearly dependent on its TMD, while Nyv1p and Vti1p self-
interactions are not dependent on their TMD. The other vacuolar SNARE proteins 
Vam7p and Ykt6p, lacking a TMD, are detected mainly as monomers. 
In vitro assembly of vacuolar full length SNARE complex composed by Vam3p, 
Nyv1p, Vam7p and Vti1p was studied by sucrose gradient coupled to co-
immunoprecipitation. The in vitro assembled complex was specifically disassembled 
by Sec18p and Sec17p in presence of ATP, like native SNARE complexes, 
demonstrating its biological relevance. Moreover, SNARE complex assembly is 
modulated by the Vam3p TMD as its deletion leads to partial formation of unspecific 
multimers. In vitro assembly of cytosolic SNARE complex, in which TMD has been 
deleted from all proteins, is also studied. In comparison with the full length SNARE 
complex, high molecular weight multimers were detected here. A pentameric SNARE 
complex with Ykt6p could not be identified in the present experimental condition.  
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2 Introduction 
2.1 Cell membranes and membrane proteins 
The boundaries of cells are formed by biological membranes, the barriers that define 
the inside and the outside of a cell. These barriers prevent molecules, generated 
inside the cell, from leaking out and unwanted molecules from diffusing in, yet they 
also contain transport systems that allow specific molecules to be taken up and 
unwanted compounds to be released from the cell. In order to fulfill this task 
membranes are dynamic structures of lipid and proteins, where lipid components 
form the permeability barrier and protein components act as a transport system of 
pumps and channels that endows the membrane with selective permeability. In 
addition to an external cell membrane, called plasma membrane, eukaryotic cells 
also contain internal membranes that form boundaries of organelles such as 
mitochondria, chloroplasts, peroxisomes, lysosomes etc. 
 
The specific function of a particular membrane is mostly determined by proteins 
residing in membrane. The importance of membrane proteins can be inferred from 
the fact that in each organism around 25-30% of all genes code for membrane 
proteins. Peripheral membrane proteins are associated with the bilayer through 
electrostatic and/or hydrophobic interactions with the surface of the membrane. In 
contrast, integral membrane proteins actually traverse the membrane with one or 
more transmembrane domains. Because the membrane interior is apolar, the 
peptide bonds, present in polypeptides traversing the bilayer, form hydrogen-bonds 
with each other, therefore protein segments generally span membrane in two 
manners: as an α-helix or a β-barrel (Figure 1).  
 
The endoplasmic reticulum (ER) is the site of protein synthesis. Thus the ER is the 
main machinery to translocate integral membrane proteins to the membrane. The 
majority of membrane proteins utilize the signal recognition particle (SRP) dependent 
pathway to be incorporated into membrane (High and Dobberstein, 1992). Cleavable 
signal peptides or signal anchors mediate the insertion of protein into the membrane. 
The Sec61 complex, localized on ER, acts as translocation machinery in which a 
protein complex composed of α,β,γ subunits and TRAM (translocating chain-
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associated membrane protein) inserts proteins into the membrane. A special type of 
membrane protein, known as “tail-anchored” proteins, are synthesized on free 
ribosomes and inserted into ER membrane post-translationally without SRP and 
Sec61 involvement. Thus membrane proteins reside on plasma membranes and/or 
on other many compartments of the cell that are originating from ER, the first 
compartment of the secretory pathway. The synthesized proteins travel through 
cargo vesicles from ER to different target compartments and those cargo vesicles 
fuse to the target membrane to deliver the molecules. 
 
 
 
 
Figure 1. Structure of two prototypical membrane proteins. A, the α-helical potassium channel 
from Steptomyces lividans. ((Cowan et al., 1992), PDB access code [1BL8]) B, the β-barrel protein 
PhoE from Escherichia coli. ((Doyle et al., 1998), PDB access code [1PHO])  
 
2.2 Membrane fusion and importance of SNARE proteins 
Membrane fusion is essential for the life of eukaryotic cells. At least three types of 
biological membrane fusion can be distinguished (Jahn et al., 2003): 
1. Extra- and intracellular fusion of pathogens with host cells. Among these, 
fusion of enveloped viruses (influenza virus, HIV), in which the entire reaction 
is carried out by a single protein, is the best characterized example.  
2. Extracellular fusion of eukaryotic cells. Examples are fusion of sperm with 
oocytes or formation of syncytia of muscle cells. 
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3. Intracellular fusion of organelles. These reactions are mediated by dynamic 
supramolecular assemblies involving conserved protein families such as 
SNARE proteins [Soluble N-ethyl maleimid-sensitive factor (NSF) attachment 
protein receptor]. 
Intracellular vesicular transport follows defined routes requiring mechanisms for 
mutual recognition and attachment of the membrane to be fused. Different members 
of the SNARE protein family fulfill this function in the secretory and the endocytic 
pathways (e.g. ER, Golgi, endosomes, lysosomes, transport and secretory vesicles 
and the plasma membrane) (Guo et al., 2000; Pelham, 2001; Zerial and McBride, 
2001). A reconstituted proteoliposome fusion assay demonstrated that SNAREs can 
act as a minimal machinery of intracellular fusion (Weber et al., 1998). The best 
characterized SNARE proteins are those mediating neurotransmitter release 
(exocytosis) from presynaptic vesicles (Sollner et al., 1993a; Sollner et al., 1993b). 
The three proteins involved in this reaction are syntaxin 1A (Bennett et al., 1992), 
SNAP-25 (25 kDa synaptosome associated protein) (Oyler et al., 1989) and 
synaptobrevin II, also known as vesicle associated membrane protein (VAMP II) 
(Baumert et al., 1989; Trimble et al., 1988). In particular, syntaxin 1A and 
synaptobrevin II are attached to the membrane by a C-terminus single membrane 
spanning domain and SNAP-25 is attached to the membrane by palmitoylation of 
four cysteine residues in the central region of the protein (Hess et al., 1992). 
SNAREs were originally classified into two groups: v-SNAREs, which are associated 
with vesicle membranes, and t-SNAREs, which are associated with target 
membranes. In the above example, synaptobrevin II is a v-SNARE while syntaxin 1A 
and SNAP-25 are t-SNAREs (Sollner et al., 1993b). However, it was found that v-
SNARE and t-SNARE can coexist on vesicles or target membranes (e.g. in 
homotypic vacuole fusion as shown in Figure 2). Therefore to avoid confusion, 
SNARE proteins were reclassified as R-SNARE (arginine containing SNAREs, e.g. 
synaptobrevin II) and Q-SNARE (glutamine containing SNAREs, e.g. syntaxin 1A 
and SNAP-25), based on a highly conserved glutamine (Q) or arginine (R) residue in 
their SNARE domain (Fasshauer et al., 1998b). All SNARE proteins share a 
homologous cytoplasmic domain, termed SNARE motif (Weimbs et al., 1997), that 
mediates their association in the core complex via formation of parallel coiled-coil 
(Jahn and Sudhof, 1999). Formation of this structure, starting from the N-termini, 
may directly precede fusion (Hanson et al., 1997a; Hay and Scheller, 1997). 
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Membrane fusion mediated by SNARE proteins can be divided into three different 
steps – priming, docking and fusion (Conradt et al., 1994; Mayer and Wickner, 1997; 
Mayer et al., 1996; Ungermann et al., 1998a; Ungermann et al., 1998b). Schematic 
representation of these three steps with comparison of heterotypic (neurotransmitter 
release) and homotypic fusion (yeast vacuole fusion) are explained in Figure 2.  
 
Two groups of components with their cofactors are involved in the different fusion 
steps: Rab proteins and SNAREs. Rab proteins constitute a family of conserved 
GTPases which are localized in different compartments (Novick and Zerial, 1997; 
Zerial and McBride, 2001). Several large effector complexes have been identified as 
tethering factor [e.g. EEA1 (involved in early endosome) (Christoforidis et al., 1999; 
Gorvel et al., 1991), TRAPP (involved in vesicle fusion to Golgi) (Barrowman et al., 
2000; Sacher and Ferro-Novick, 2001; Sacher et al., 1998), HOPS (involved in 
vacuole fusion) (Price et al., 2000a; Price et al., 2000b; Sato et al., 2000; Seals et 
al., 2000)] for Rab GTPases and those are required for an initial binding of the fusion 
partners (Figure 2, panel A). Rab GTPases and tethering factors are intimately linked 
to SNAREs. The localization of Rabs and SNAREs shows significant but not 
absolute compartment specificity. Therefore, specificity of transport could be 
achieved in a combinatorial fashion relying on the combination of particular Rab 
proteins with particular tethering factors and SNAREs for certain trafficking routes 
(Mayer, 2001; Mayer, 2002).  
 
In homotypic fusion Q- and R-SNAREs are forming complexes in the same 
membrane (cis-complexes) (Figure 2, Panel A). These cis-complexes can be 
disrupted (Fasshauer et al., 2002; Fasshauer et al., 1997a; Fasshauer et al., 1997b; 
Nichols et al., 1997; Ungermann et al., 1998b; Ungermann et al., 1999a) by the ATP-
driven chaperon NSF (Whiteheart et al., 1992; Wilson and Rothman, 1992; Wilson et 
al., 1992) and its cofactor α-SNAP (Clary et al., 1990; Clary and Rothman, 1990; 
Whiteheart et al., 1993), yielding activated SNAREs, which are then competent to 
form trans-SNARE complexes, defined as association between Q- and R-SNAREs 
from the opposing membranes (Figure 2, panel A) (Banerjee et al., 1996; Hanson et 
al., 1997b; Hay and Scheller, 1997; Mayer et al., 1996; Ungermann et al., 1998b). In 
homotypic fusion, formation of trans-complexes mediates docking, the second stage 
of the membrane attachment, thus yielding close and strong apposition of the two 
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membranes. The last step, lipid mixing of the two adjacent bilayers (fusion) occurs 
after formation of the trans-complexes, and it is triggered by Ca2+ ion (Peters and 
Mayer, 1998; Ungermann et al., 1999b; Wada et al., 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Mechanism of SNARE-mediated membrane fusion. A, Homotypic fusion, Mutual 
recognition and attachment of membranes during fusion depends on Rabs, SNAREs and tethering 
factors. Rab proteins cooperate with large complexes of the tethering factors to mediate an initial 
interaction (priming). The ATPase NSF and α-SNAP disrupt cis-SNARE complexes (SNARE 
complexes on the same membrane) by ATP hydrolysis and activate (prime) SNAREs (*) to form trans-
complexes between the membrane (docking), which probably coincides with close apposition of the 
membranes. The final step is mixing of lipid bilayer (fusion). Adapted and modified from the reference 
(Mayer, 2001). B, Heterotypic fusion, Syntaxin 1A is bound to n-Sec1 before formation of the core 
complex. Rab proteins might facilitate the dissociation of n-Sec1 from syntaxin, allowing subsequent 
binding between the three neuronal SNAREs; syntaxin, SNAP-25 and VAMP (for simplicity, only one 
coil is drawn for SNAP-25) (docking). Ca2+ triggers the full zipping of the coiled-coil complex (priming), 
which results in membrane fusion and release of vesicle contents. After the fusion event, recruitment 
of α-SNAP and NSF from cytoplasm and subsequent hydrolysis ATP by NSF causes dissociation of 
the SNARE complex. Syntaxin, VAMP and SNAP-25 are then free for recycling and another round of 
exocytosis (Chen and Scheller, 2001).  
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Homotypic and heterotypic fusion events share many common steps, but also some 
typical differences. The two sequential steps: priming and docking of homotypic 
fusion are inverted in heterotypic fusion (Broadie et al., 1995; Hunt et al., 1994; 
Schulze et al., 1995). In heterotypic fusion it has not been yet identified a “clear” cis-
complex, as for homotypic fusion (Figure 2, panel A); thus “true” priming step, where 
ATP driven NSF/α-SNAP disrupts the cis-complex, cannot be described. In 
heterotypic membrane fusion NSF/α-SNAP are required after the membrane fusion, 
in order to release individual SNARE proteins from the complex, thus allowing 
another round of exocytosis (Figure 2, panel B). Calcium ion is playing important role 
in heterotypic fusion (Chen et al., 1999) as well as in homotypic fusion. The probable 
mechanism for lipid mixing is described below. 
2.3 SNARE hypothesis and membrane fusion 
Membranes do not fuse spontaneously because the repulsive energy between two 
opposing phospholipids membranes in an aqueous environment is very high. These 
forces need to be overcome in order to reach the metastable transition state that 
leads to fusion (Jahn and Grubmuller, 2002; Jahn et al., 2003; Jahn and Sudhof, 
1999). Two extreme hypotheses of membrane fusion have been proposed. Some 
authors (Jahn and Sudhof, 1999; Mayer, 2001; Mayer, 2002; Monck et al., 1995) 
postulate that fusion of membranes is primarily mediated by phospholipids (stalk 
formation), with the role of proteins restricted to reducing the activation energy and 
spatially organizing the fusion site. According to this hypothesis, fusion of lipid 
membranes requires at least five distinct steps: approach to short distance, local 
perturbation of the lipid structure and merger of proximal monolayers, stalk 
formation, stalk expansion, known as hemifusion, and finally mixing of second layer 
or full fusion (Figure 3 panel A) (Chernomordik et al., 1987; Jahn and Grubmuller, 
2002; Kozlov and Markin, 1983).   
 
Other authors (Almers and Tse, 1990; Jahn et al., 2003; Jahn and Sudhof, 1999; 
Lindau and Almers, 1995; Mayer, 1999; Mayer, 2001; Mayer, 2002) propose initial 
fusion pore formation with transmembrane proteins and lipids. The fusion pore is 
depicted as a channel that spans two opposing membranes and forms oligomeric 
ring structure. Thus, the aqueous fusion pore would be initially lined by proteins and 
only subsequently invaded by phospholipids (Figure 3, panel B). The model implies 
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that nonbilayer transition states of the fusing membrane are governed by protein-lipid 
interactions, which may be both hydrophilic and hydrophobic. The proteins could 
guide the lipids at the contact sites through non bilayer structures that they may not 
form in the absence of the proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Models for membrane fusion. A, Stalk hypothesis, vesicles approach to close contact 
followed by local perturbation of lipid structure and merger of outer monolayer (hemifusion). Finally, 
inner monolayer mixing produces the full fusion. B, Fusion pore model. A continuous proteinaceous 
assembly forms between membranes. The pore subunits partially dissociate in the plane of the 
membrane, leading to the radial opening of this proteinaceous pore (ROPP). Concomitant with this, 
lipids invade the amphiphilic clefts between the subunits, enabling their migration between the 
membranes. Adapted and modified from reference (Mayer, 2002). Other proteins involved in 
membrane fusion are omitted to simplify the picture. 
 
vesicles
hemifusion
full fusion
A
pore formation
pore opening
B
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SNARE hypothesis postulates that the assembly of SNAREs mediates the 
attachment of membranes before fusion and that NSF-driven disassembly would 
lead to fusion completion. Furthermore, v-SNARE and t-SNARE interactions 
determine the specificity of intracellular vesicle traffic, i.e. that a single SNARE would 
function only in a single trafficking step (Rothman, 1994a; Rothman, 1994b; Sollner 
et al., 1993a; Sollner et al., 1993b). This hypothesis was the first attempt to intigrate 
SNAREs membrane localization and the assembly-disassembly cycle of SNAREs 
with membrane fusion. Later it was discovered that NSF does not participate in 
fusion itself, as already described (Figure 2) it is required after (in heterotypic fusion 
(Banerjee et al., 1996; Bittner and Holz, 1992; Littleton et al., 1998)) or before (in 
homotypic fusion (Mayer and Wickner, 1997; Mayer et al., 1996)) fusion step to 
release individual SNAREs. Different studies questioned the specificity of SNARE 
pairing since recombinant cytoplasmic domains of SNARE proteins interacted 
promiscuously in binding assay (Fasshauer et al., 1999; Yang et al., 1999). On the 
other hand, in liposome or cellular fusion experiments, recombinant full-length 
SNAREs interact specifically (Brugger et al., 2000; Scales et al., 2000). These 
results suggest that SNARE pairing in lipid bilayers may be more specific than in 
solution. Another hypothesis proposed that the specificity can be determined by a 
combination of SNARE protein complex with Rab proteins, tethering factors etc 
(Figure 2) (Mayer, 2001; Mayer, 2002). However it is still matter of debate, whether 
such activity is sufficient to account for the precise and fast fusion necessary within 
the cells. 
2.4 Structure of SNARE interaction domain 
SNARE proteins are typically characterized by the presence of SNARE motif, 
approximately 60-70 residues length, located immediately adjacent to a C-terminus 
transmembrane anchor (Weimbs et al., 1997). The SNARE motif consists of heptad 
repeat pattern of residues, spaced such that the adoption of an α-helical structure 
places all the relevant side chains on the same face of the helix (Ungar and 
Hughson, 2003). In trans-SNARE complex formation the SNARE motifs assemble 
into parallel four helix bundles (3 Q-SNAREs and 1 R-SNARE), stabilized by the 
burial of these helix faces in the bundle core (Figure 4) (Antonin et al., 2002; Poirier 
et al., 1998b; Sutton et al., 1998). Investigators have visualized two different SNARE 
complexes (the synaptic SNARE and endosomal SNARE) at high resolution using X-
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ray crystallography. This landmark structure revealed that an arginine (R) and three 
glutamine (Q) residues compose a polar layer by forming a hydrogen-bonded 
network sequestered from the solvent (Antonin et al., 2002; Sutton et al., 1998).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Neuronal SNARE core complex with SNARE domain. Synaptic SNARE proteins form a 
four helix bundle via a parallel coiled-coil structure. Synaptobrevin II (blue) and syntaxin 1A (red) 
contribute one helix each to the complex whereas SNAP-25 (green) contributes two helices. TMDs 
are presented in yellow. This picture is adapted and modified from the reference (Sutton et al., 1998) 
 
In addition to the SNARE motif, several SNAREs, such as syntaxin 1A, have an N-
terminus domain that can back fold onto the SNARE motif and thus exist in closed or 
open form (Dietrich et al., 2003; Fasshauer, 2003; Ungar and Hughson, 2003). In the 
isolated syntaxin 1A, N-terminus Habc domain (see Figure 6 for comparison), a three 
helix bundle, is bound intramolecularly to the coiled-coil domain of SNARE motif in 
the closed conformation (Fasshauer, 2003; Fernandez et al., 1998; Lerman et al., 
2000; Margittai et al., 2003). Munc 18-1 binding with syntaxin 1A converts the closed 
form to open form via unknown mechanism, allowing the formation of the trans-
complexes with synaptobrevin II and SNAP-25 (Dietrich et al., 2003; Fasshauer et 
al., 1998a; Poirier et al., 1998a). A similar behavior was described also in case of 
Sso1p (Munson et al., 2000), a syntaxin 1A homolog on yeast plasma membrane; 
interestingly assembly of SNARE complex formation in vitro is accelerated 2000-fold 
in the absence of Sso1p N-terminus domain (Nicholson et al., 1998). In the late 
endocytic pathway the interaction between the N-terminus domain of the syntaxins, 
Vam3p and Pep12, is not important, since these proteins do not adopt a closed 
conformation with N-terminus three helix bundle (Dietrich et al., 2003), even if the N-
terminus domain mutant of Vam3p vacuoles fuse with markedly reduced efficiency 
Synaptobrevin
SNAP-25
vesicle
plasma membrane
Syntaxin
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(Laage and Ungermann, 2001). This is probably due to its poor interaction with NSF 
and α-SNAP proteins, required for the disruption of cis-complexes (Dietrich et al., 
2003). 
 
The amino terminus of the synaptobrevin family is of different length, ranging from a 
few up to 150 residues. Recent studies revealed significant sequence homology of 
this N-terminus domain of synaptobrevins, allowing further classifications of 
synaptobrevin family as longins (Dietrich et al., 2003). Two studies, addressing the 
longin domains of VAMP7 and Ykt6p, suggest an autoinhibitory mechanism 
(Martinez-Arca et al., 2000; Tochio et al., 2001), that is reminiscent of the closed 
syntaxin conformation. A hydrophobic patch in longins of Ykt6p can bind with the 
SNARE motif. The mutation in a crucial residue F42E of the hydrophobic patch is 
sufficient to break this interaction in an in vitro assay (Martinez-Arca et al., 2000). In 
contrast to Sec22p, which contains similar hydrophobic patch in a similar spatial 
orientation, an interaction between longins and SNARE motif was shown to be 
unlikely (Gonzalez et al., 2001). 
 
The SNAP-25 (Q-SNARE) does not contain a TMD, but is attached to the membrane 
via lipid anchor (Hess et al., 1992). The yeast vacuolar protein, Vam7p, or the yeast 
plasma membrane SNARE Sec9p and its homolog Spo20p, shows homology to 
SNAP-25 family, but these proteins are not bound to membrane via lipid anchor 
(Dietrich et al., 2003). The yeast vacuolar SNARE Vam7p is found both in cytosol 
and on the vacuole (Sato et al., 1998). Vam7p contains an N-terminus PX domain 
(named after the NADPH oxidase subunits p40phox and p47phox). PX domains were 
identified as novel phosphatidylinositol phosphate binding proteins, most of them 
having a preference for phosphatidylinositol 3-phosphate (Cheever et al., 2001; Sato 
et al., 2001; Wishart et al., 2001). PX-domain consists of a module of three β-strands 
and three to four α-helices (Lu et al., 2002) that bind to phosphatidylinositol 3-
phosphate, thus probably inserting part of the PX domain into lipid bilayer (Cheever 
et al., 2001). During exocytosis, Sec9p, the SNAP-25 homologue in the yeast 
plasma membrane, acts together with the syntaxin like t-SNARE Sso1p (Dietrich et 
al., 2003). During spore formation, Sec9p is replaced by Spo20p, which is 40% 
homologous to Sec9p and essential for sporulation (Neiman, 1998). Interestingly, 
despite the substantial overall homology of these proteins, the N-terminus domains 
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appear to have distinct functions. Replacement of Sec9p N-terminus by the one of 
Spo20p inhibits vegetative growth, while surprisingly removal of the Sec9p N-
terminus does not affect fusion (Neiman et al., 2000). 
2.5 Structure – function analysis of yeast vacuolar SNAREs 
The yeast vacuole is critical for yeast viability. The vacuole is analogous to the 
mammalian lysosome and is required for the turnover of selected proteins (Hicke, 
1999; Klionsky et al., 1990). It is the site of storage of phosphate, selected amino 
acids, metals and selected toxins. In addition, the yeast vacuole helps in buffering 
the pH of the cytoplasm and it is important in water and ion homeostasis, thus 
playing multiple roles in the response to cellular stresses (Catlett and Weisman, 
2000; Weisman, 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Vacuole inheritances in budding yeast. Vacuole begins to migrate into budding daughter 
cell early in G1 phase. After cell division segregated vacuoles fuse among themselves to form one to 
two organelles per cell. Vacuoles were visualized with the fluorescent FM4-64 (Vida and Emr, 1995). 
This picture is adapted and modified from reference (Conradt et al., 1992). 
 
The vacuole of the budding yeast is actively divided between mother and daughter 
cells. Vacuole inheritance initiates early in the cell cycle, prior to the bud emergence 
and ends in G2, just prior to nuclear migration (Figure 5). The process begins with a 
portion of the vacuole extending into an emerging bud (Conradt et al., 1994). This 
tubular-vesicular entity, called the segregation structure, enables continued 
exchange of the vacuole contents between mother and daughter vacuoles (Catlett 
G1 S G2 M G1
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and Weisman, 2000; Weisman, 2003). The segregation of vacuole from mother to 
daughter cell in budding yeast is known as vacuole fission. In mating cells, 
segregated structures fuse rapidly in the zygote bud, allowing the exchange of 
membranes and lumen contents via bud vacuole (Wang et al., 1998; Weisman et al., 
1987; Weisman et al., 1988). Vacuole fusion is also required for normal vacuolar 
morphology, as mutants that are defective in fusion often have highly vesiculated 
vacuoles (Price et al., 2000b). Vacuole fusion also takes place in response to hypo-
osmotic stress, enabling a rapid increase in vacuole volume (Catlett and Weisman, 
2000). 
 
Homotypic (self) fusion of yeast vacuoles, which is essential for the low copy number 
of this organelle, is mediated by SNARE proteins. Studies of homotypic vacuole 
fusion suggested a modified paradigm of membrane fusion, in which SNARE 
proteins form stable cis-complexes as well as trans-complexes (Figure 2). 
Chaperons as NSF/Sec18p and α-SNAP/Sec17p disassemble cis-complexes to 
prepare for the docking of organelles rather than driving fusion. The specificity of 
organelle docking resides in a cascade of trans-interactions (involving Rab-like 
GTPases), “tethering factors”, and trans-SNARE pairing. Fusion itself, the mixing of 
the membrane bilayer and the organelle contents, is triggered by calcium signaling 
(Wickner and Haas, 2000). Five SNARE proteins are involved in yeast vacuole 
fusion: Vam3p, Nyv1p, Vti1p, Vam7p and Ykt6p (Darsow et al., 1997; Nichols et al., 
1997; Ungermann et al., 1998b; Ungermann et al., 1999a; Ungermann and Wickner, 
1998). 
 
Figure 6 shows a schematic representation of the different domains of the yeast 
vacuole SNARE proteins studied in this thesis. 
 
 
 
 
 
 
 
 
Figure 6. Schematic representation of yeast vacuolar SNARE proteins. 
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In the yeast vacuole the syntaxin homolog Vam3p (Wada et al., 1997) has a single 
membrane spanning domain at the C-terminus end (Darsow et al., 1997; Dulubova 
et al., 2001). At the functional level, complete deletion of Vam3p from yeast strain 
does not interfere with the viability of the cell, but prevent vacuole-vacuole fusion. 
Jones et al. observed that when Vam3p is deleted from yeast cell, alkaline 
phosphatase, a vacuolar membrane hydrolase, accumulates in the precursor form 
and the maturation of pro-aminopeptidase I, a hydrolase precursor delivered to 
vacuole from the cytoplasm, is blocked due to fusion defects (Srivastava and Jones, 
1998). Recent studies revealed that the C-terminus TMD is very important for the 
vacuole fusion, since its deletion and replacement with a prenyl anchor at the C-
terminus causes a reduced vacuole fusion efficiency up to 4 fold compared to wild 
type. This deletion of C-terminus TMD of Vam3p also reduces the palmitoylation of 
Vac8p, a reaction required beyond trans-SNARE complexes (Rohde et al., 2003) 
(Figure 7).  
 
The yeast vacuole R-SNARE, Nyv1p is a synaptobrevin analog that contains an 
integral membrane spanning domain at the C-terminus (Fischer von Mollard and 
Stevens, 1999; Nichols et al., 1997). In functional studies, deletion of Nyv1p is 
associated with less pronounced defects in the in vitro fusion that can be rescued by 
adding extra recombinant Vam7p (Thorngren et al., 2004). The authors suggested 
that recombinant Vam7p could mediate fusion, in absence of Nyv1p, employing 
Ykt6p as the R-SNARE. A similar situation is also observed in yeast ER-to-Golgi 
transport, where Ykt6p can substitute for the R-SNARE Sec22p (Liu and Barlowe, 
2002; Thorngren et al., 2004) (Figure 7). 
 
The SNAP-25 analog in yeast vacuole is Vam7p, a Q-SNARE. Vam7p does not 
contain any TMD and it is attached to the membrane via PX-domain, which binds the 
phosphatidylinositol 3-phosphate (Cheever et al., 2001; Sato et al., 1998) (Figure 7). 
At the functional level, deletion of Vam7p from yeast cells does not affect cell 
viability, but creates fragmented vacuole. Vam7p is distributed in cytosol and on the 
vacuolar membrane (Boeddinghaus et al., 2002; Sato et al., 1998; Sato et al., 2001). 
Recent in vivo studies show that inhibition of Sec18p, an NSF protein required for 
yeast vacuole fusion, shifts most of Vam7p to the vacuole (Sato et al., 1998), thus 
suggesting that Vam7p cycles between the vacuolar membrane and the cytosol: 
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during Sec18p/ATP dependent priming, up to 90% of Vam7p is released from the 
vacuolar membrane as monomer (Dietrich et al., 2003) (Figure 7). The released 
Vam7p is a functional intermediate, as it can rescue fusion of vacuoles depleted of 
Vam7p; and the PX domain is important for this rescue, since the C-terminus coiled-
coil domain of Vam7p or a Vam7p proteins mutated in its PX-domain, do not rescue 
fusion (Boeddinghaus et al., 2002; Cheever et al., 2001). It is likely that association 
of the PX-domain to phosphoinositide target is a prerequisite for the migration of 
Vam7p to the fusion site ((Dietrich et al., 2003)). 
 
 
 
 
Figure 7. Yeast vacuolar SNARE proteins. The five SNARE proteins of yeast vacuole are presented 
as Qa, Qb, Qc and R. Among these Vti1p is involved in other vesicle trafficking pathway like trans-
Golgi network to prevacuolar compartment and retrograde trafficking to cis-Golgi. Ykt6p is also 
involved in vesicle trafficking between ER to cis-Golgi and trans-Golgi to PVC. Ykt6p is also involved 
in Vac8p palmitoylation (Pal-Vac8p) which is Sec18p dependent. Vam7p is recruited to vacuolar 
membrane from cytosol by phosphatidylinositol 3-phosphate (PI-3-P); Sec18p driven cis-complex 
disruption release majority of Vam7p in cytosol.  Sec17p is α-SNAP analog in yeast vacuolar fusion. 
Other proteins, required for vacuolar fusion, are omitted for the simplicity of the picture. This picture is 
adapted and modified from reference (Burri and Lithgow, 2004)  
 
Vti1p is a Q-SNARE, containing a single membrane spanning domain at C-terminus. 
In vivo studies show that deletion of Vti1p leads yeast cell to death (Dilcher et al., 
2001). This protein is involved in vesicle transport from trans-Golgi network to pre-
vacuolar compartment, in retrograde trafficking to cis-Golgi and in vacuolar 
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membrane fusion (Fischer von Mollard and Stevens, 1999; Fischer von Mollard et 
al., 1997) (Figure 7).  
 
Ykt6p is an R-SNARE without any TMD. It is attached to the membrane via 
prenylation at the C-terminus. The yeast cell can not survive if Ykt6p is deleted 
(McNew et al., 1997). This protein is involved in trafficking vesicles from ER to Golgi 
and in vacuole fusion where it interacts with Vti1p (Dilcher et al., 2001; Fischer von 
Mollard et al., 1997; McNew et al., 1997; Ungermann et al., 1999a). Ykt6p also 
shows weak interaction with COPII coat component (Springer and Schekman, 1998). 
Recent studies showed that Ykt6p is involved in the palmitoylation of Vac8p, 
described to be essential for vacuole fusion (Dietrich and Ungermann, 2004; 
Fukasawa et al., 2004) (Figure 7). 
2.6 The importance of TMD in SNARE interactions and membrane 
fusion 
Membrane fusion is the fundamental step for the transfer of proteins and lipids 
between different compartments, for exocytosis and for the structural integrity of the 
organelles. The components required for membrane fusion and the specificity for the 
selection of the correct target membrane are discovered, but the precise mechanism 
of lipid mixing is still unknown yet. Investigators are discussing several scenarios of 
TMDs, how it might promote lipid bilayer mixing. According to the “zipper” model, 
assembly of the SNARE ternary complex begins at the N-terminus SNARE domains 
and progresses towards the membrane anchors, gradually bringing membrane into 
close proximity where interaction between the TMDs may be associated with the 
formation of a fusion stalk (Margittai et al., 1999). 
 
Exocytosis in yeast requires the assembly of the vesicular membrane Snc1p (v-
SNARE) and the plasma membrane Sso2p and Sce9p (t-SNAREs). Grote et al. 
showed that when Snc1p and Sso2p were incorporated via geranylgeranylation at 
the C-terminus instead of their TMD, yeast exocytosis is blocked, even if a 
successful docking of vesicles to the plasma membrane was observed (Grote et al., 
2000). Thus the TMDs appear to play a vital role in the fusion process. 
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Synaptobrevin II, an essential SNARE protein for neurotransmitter release, is 
forming homodimer in synaptic vesicle membrane (Calakos and Scheller, 1994; 
Edelmann et al., 1995; Washbourne et al., 1995) and as a recombinantly expressed 
protein in detergent solution, a membrane mimicking condition (Laage and 
Langosch, 1997). Dimerization is strongly dependent on the specific TMD sequence 
of synaptobrevin II since its mutation can disrupt it and this sequence motif is 
conserved for heterophilic interaction with syntaxin 1A (Laage et al., 2000). 
Synaptobrevin II and syntaxin 1A dimerization was also observed by other methods 
such as ToxR (Laage et al., 2000; Roy et al., 2004) and liposome fusion assay 
where these proteins were reconstituted in liposomes (Margittai et al., 1999). TMD-
TMD interactions may play a role at different stages of SNARE protein interaction. 
First, the affinity of homophilic TMD-TMD assembly can regulate the trans-SNARE 
complex formation. Second, the heterophilic interaction by TMD can lead to 
multimerization of SNARE complexes (Poirier et al., 1998b), as it was observed by 
electron microscopy, where dimers and multimers of native or recombinant SNARE 
complexes are associated at the sites of the TMDs; on the contrary multimerization 
was absent with SNARE complexes composed of cytoplasmic domains only (Hohl et 
al., 1998). Though the functional relevance for SNARE complex multimerization is 
not known, but it could be possible that these multimers can stabilize the cis-
complex. Third, heterophilic TMD-TMD interaction may stabilize the trans-SNARE 
complex by complete zipping of SNARE proteins (Laage et al., 2000; Margittai et al., 
1999); this can facilitate the lipid mixing by structural flexibility of TMD. Langosch et 
al. showed that incorporation of the TMD peptides of synaptobrevin II or syntaxin 1A 
into the synthetic liposomes strongly increase their ability to fuse, thus suggesting a 
potential fusogenic activity of the TMDs. Structural studies of synaptobrevin II TMD 
peptide revealed a co-existence of α-helical and β-sheet conformations. The authors 
suggested that the conformational plasticity of TMD may be important for the SNARE 
protein function at a late step in membrane fusion, since fusogenic activity 
significantly decreases if the α-helical property of synaptobrevin II TMD peptide is 
stabilized by mutation (Langosch et al., 2001). When full length syntaxin and 
synaptobrevin are anchored to liposome via short fatty acid chain, the liposome 
fusion is prevented, whereas fatty acid lipid anchors that potentially span lipid 
bilayers allowed for fusion, suggesting a particular length of transmembrane 
segment requirement for membrane fusion (McNew et al., 2000). Experiments on 
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C.elegans revealed that mutations that affect synaptobrevin or syntaxin TMDs result 
in severe neurotransmission defect (Nonet et al., 1998; Saifee et al., 1998) and 
syntaxin isoforms in C.elegans (Saifee et al., 1998) and vertebrates were identified 
that are only distinguished by their TMD sequence (Bennett and Scheller, 1993; 
Ibaraki et al., 1995). Rohde et al showed that deletion or mutation of Vam3p TMD, a 
syntaxin analog in yeast vacuole; affect the efficiency of membrane fusion as 
described in the previous section (Rohde et al., 2003). In conclusion, SNARE-TMDs 
seem to act as autonomous domains.  
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3 Aim of the work 
In the first part of the thesis the TMD dependent homodimerization of synaptobrevin 
II is presented. Homodimerization of synaptobrevin II was previously shown by 
different authors to depend on its single TMD, and the crucial residues forming helix–
helix interface have been mapped. Since another recent study challenged these 
results, we re-examined this under different experimental conditions. 
 
Rohde et al revealed by functional analysis that the deletion of the Vam3p TMD or 
mutation in TMD does not affect the localization of the Vam3p in yeast vacuole, but 
the vacuole fusion is severely affected. Considering the importance of TMD in 
vacuole fusion and the established role of TMD–TMD interaction in presynaptic 
SNARE interactions, the main aim of this work was to clarify whether TMD of Vam3p 
would contribute to homo- or heterophilic yeast SNARE interactions in vitro. Thus, 
we wished to clarify, whether the functional effect of the TMD alteration could be 
correlated to its interactions.  
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4. Materials and methods 
4.1 Chemicals 
4.1.1 General chemicals 
Unless specified otherwise, the standard chemicals have been obtained from the 
following companies: Roth (Karlsruhe), J.T.Baker (Holland), Merck (Darmstadt), 
Sigma (Munich), Applichem (Darmstadt). All solutions were prepared with deionised 
water (Millipore filter unit). 
4.1.2 Detergent 
CHAPS (3-[3-cholamidopropyl-dimethylammonio]-1-propansulfonat), Triton® X-100 
and sodium dodecyl sulfate (SDS) were from Applichem. Thesit® 
(dodecylpoly[ethyleneglycolether]n) was obtained from Fluka. 
4.1.3 DNA-modifying enzyme 
DNase I was from Roche (Mannheim). Restriction endonucleases, T4 DNA ligase 
and Taq polymerase were obtained from MBI Fermentas. Turbo Pfu polymerase and 
Dpn I were obtained from Stratagene. 
4.1.4 Antibodies 
Polyclonal antibodies, α-Vam3p, α-Nyv1p, α-Vti1p, α-Vam7p and α-Ykt6 were a gift 
of Dr. Christian Ungermann (BZH, Heidelberg). Myc monoclonal antibody 9E10 was 
extracted from the supernatant of hybridoma cells. Enzyme-conjugated secondary 
antibodies: Goat-anti-mouse HRP conjugated and Goat-anti-rabbit HRP conjugated 
were obtained from Promega. 
4.1.5 Kits 
PCR purification kit, Plasmid purification kit and DNA isolation from agarose gel kit 
were obtained from Macherey Nagel (Düren). DNA sequencing was performed with 
SequiTherm EXCELTM II DNA sequencing kit (BioZyme). 
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4.1.6 Synthetic Oligonucleotides 
Synthetic oligonucleotides for PCR and mutagenesis were obtained from Invitrogen 
(Scotland). Sequencing primers were obtained from MWG-Biotech (Ebersberg). 
Longer oligonucleotides (100mers) were obtained as PAGE purified from 
ThermoHybaid.  
 
Primer DNA sequencing 
T7 promoter primer 
IRD700-TAATACGACTCACTATAGGG 
T7 terminator primer 
IRD800-GCTAGTTATTGCTCAGCGG 
Vam3p∆TM primer 
CAGGGTCTCGAGACCGCATTTGTTACGGTCCCT 
Nyv1p∆TM primer 
AATTTTGGATCCTTCTGCCACCACATTATTTC 
Vti1p∆TM primer 
ATTAGCGAATTCCCTTCTAGTCATTGTTTTTAG 
Vam3p Ala20 primer 
CAGGGTCTCGAGACTGGCGGCTGCTGCTGCTGCGGCTGCGGCTGCGGCGGCT
GCGGCTGCGGCTGCTGCTGCTGCGCATTTGTTACGGTCCCTCTGATGC 
Nyv1pAla21primer 
CAGGGTGGATCCCAGGCGGCGGCTGCTGCTGCTGCTGCTGCGGCTGCGGCG
GCTGCGGCTGCGGCTGCTGCTGCTGCATTTTTGACCTTCTGCCACCACATTATT
TC 
Vti1pAla23primer 
CAGGGTGAATTCTTTAAACTTTGAGGATGCTGCGGCGGCGGCTGCTGCTGCTG
CGGCTGCGGCTGCGGCGGCTGCGGCTGCGGCTGCTGCTGCTGCCCTTCTAGT
CATTGTTTTTAGTGTC 
Vam3pC274A I 
CATTATAATAGTTGTGGCCATGGTGGTATTGC 
Vam3pC274A II 
GCAATACCACCATGGCCACAACTATTATAATG 
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4.1.7 Vectors  
Synaptobrevin II (from R. norvegicus) was cloned in pSNiR-series vectors (Laage 
and Langosch, 1997; Laage and Langosch, 2001). Vam3p, Vti1p and Vam7p were 
cloned in pET28a, and Nyv1p was cloned in pET15b. Ykt6 protein was cloned in 
pGEX4T-1 and Ykt6p was subcloned into pET28a vector. We are thankful to Dr. 
James Rothman for providing these cloned yeast genes in different vectors. 
Vam3pA4 and Vam3pA4bb mutants are generous gift from Dr. Jan Rhode and these 
mutants were subcloned into pET28a. 
4.1.8 Bacterial strains  
All bacterial strains used are modifications of Escherichia coli. The BL21, 
BL21(DE3)pLysS and Rosetta (DE3) strains were obtained from Novagen. The M15 
strain was obtained from Quiagen for expression of Sec17p and Sec18p. The strain 
DH5α was used for normal cloning procedure and DNA-plasmid preparations. 
4.2 Preparative and analytical DNA-techniques. 
4.2.1 Plasmid DNA MINI preparation 
Single bacterial colonies were inoculated into LB-medium containing appropriate 
antibiotic and grown overnight at 37oC in a shaker. The grown cultures were 
centrifuged for 10 min at 14000xg, the supernatant was discarded and the pellet was 
resuspended in 150 µl Sol I. After 5 min incubation at room temperature (RT), 200 µl 
Sol II was added and the solutions were mixed by inverting the tubes fro 5-10 times. 
The mixture was incubated 5 min at RT, thereafter 150 µl of cold sol III was added, 
and the tube was inverted for 5-10 times and then incubated on ice for 5 min and 
centrifuged at 4oC with 14000xg for 15 min. The supernatant was collected from the 
tube and mixed with phenol:chloroform:isoamyl alcohol (25:24:1) by vortexing for 10-
30 sec. The aqueous layer and organic layer were separated by centrifuging the 
mixture at RT for 15 min at 14000xg. The aqueous layer was carefully collected from 
the upper part and 1/10th volume of 5 M sodium acetate pH 5.2 was added to that. 
Equal volume of iso-propanol was added and incubated at RT for 5-10 min to 
precipitate plasmid DNA. Subsequently the DNA was precipitated via centrifugation 
at 4oC 14000xg for 30 min., the precipitated DNA was washed with 70% ethanol and 
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dried at RT. The precipitate was then resuspended into 30 µl TE (10 mM Tris pH 
8.0), 1 mM EDTA or H2O. 
Sol I 
50 mM Tris-HCl; pH 8.0 
10 mM EDTA 
100 mg/ml RNase 
Sol II 
0.2 N NaOH 
1% SDS (w/v) 
Sol III 
3 M potassium acetate 
2 M Acetic acid 
4.2.2 Agarose gel electrophoresis of DNA 
DNA and fragments after restriction digestion were analysed by agarose gel 
electrophoresis, using electrophoresis chamber TypM100 from EMBL, Heidelberg. 
0.8-1.5% (w/v) Ultrapure agarose solutions in TBE (45 mM Tris-borate; 1 mM EDTA, 
pH 8.0) were heated in a microwave oven to dissolve the agarose and 2 µl 
ethidiumbromide (10 mg/ml) was added when the solution was cold but not solidified. 
TBE was used as running buffer. 
4.2.3 Restriction digestion 
Vector DNA or PCR DNA fragments were digested with restriction endonucleases to 
generate DNA fragment for cloning. The calculation of the amount of enzyme was 
done according to the following formula:  
 
 
 
 
Digestion mix  0.1-5 µg DNA 
   + 0.1 vol digestion buffer 
   + H2O to final volume 
   + max 0.1 vol enzyme 
   incubation from1h till overnight at 37oC  
(µg DNA x number of cuts x 50) 
(kb x cuts in λ) 
= units enzyme 
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4.2.4 Analysis and isolation of DNA fragments from agarose gels 
Gel pieces with the desired DNA fragment were cut out from the agarose gel with a 
sterile scalpel and transferred into a 1 ml tubes. The DNA was extracted from the gel 
piece according to the protocol described in the Macherey Nagel kit protocol. The 
isolated DNA was visualized again on agarose gel. 
4.2.5 Amplification of specific DNA sequences  
Specific DNA fragment was amplified by polymerase chain reaction (PCR). Taq DNA 
polymerase was used in all PCR reaction. The reaction was made according to the 
MBI Fermentas protocol sheet. For 100 µl reaction mixture, the composition was as 
follows: 
DNA template     1 µl (25-100 ng) 
  Taq DNA polymerase buffer 10 µl (10x from MBI) 
  with 15 mM MgCl2  
  Sense primer     1 µl (100 pmol/µl stock) 
  Antisense primer     1 µl (100 pmol/µl stock) 
  dNTP mix      2 µl (10 mM stock) 
  Taq DNA polymerase    1 µl (1 unit/µl) 
  H2O     84 µl 
Amplification was performed on an Eppendorf Robocycler. The reaction protocol was 
as follows: 
  94oC   5 min 
  55oC   2 min  
  94oC  40 sec 
  55oC   40 sec        35 cycles 
  72oC   1 min 
  94oC   1 min  
  55oC   40 sec 
  72oC  20 min 
    4oC  Hold  
 
The PCR products were purified by PCR purification kit from Macherey Nagel and 
detected by agarose gel electrophoresis. 
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4.2.6 DNA fragment ligation 
DNA ligation was performed in a 10 µl reaction mixture. The protocol was as follows:  
  Vector DNA   1 µl (100 ng) 
  Insert DNA  5-10 times molar amount of vector DNA 
  Ligase buffer  1 µl (5 Weiss unit/µl) 
  H2O   to add up 10 µl 
4.2.7 Preparation of chemical competent cells (according to Inoue 
method) 
The production of competent E.coli strain DH5α, BL21, BL21(DE3)pLysS, 
Rosetta(DE3) and M15 was done according to the method of Inoue (Inoue et al., 
1990). One colony was inoculated with or without appropriate antibiotic and 1% 
glucose from a fresh plate. The cells were grown for min 6-8 hrs at 37oC, thereafter 
1-2 µl culture was inoculated into 100 ml SOB medium with 2.5 ml of 2 M MgCl2 and 
incubated at 25oC until the OD600 reached 0.45-5 (approximately 13-15 hours). The 
culture was then cooled on ice for 10-30 min. The cells were then harvested at 4oC 
at 4000xg and resuspended with 16 ml HTB buffer, centrifuged again and finally 
resuspended in 4 ml HTB buffer and 300 µl DMSO (or 6-7% of the total volume) was 
added to the cell suspension. The bacterial suspension was then aliquoted in 
different tubes and immediately frozen in liquid nitrogen and stored at -80oC.   
SOB medium:  2% Bactotrypton 
    0.5% Bacto yeast extract 
    9 mM NaCl 
    2.5 mM KCl 
    10 mM MgCl2 
 
HTB:    10 mM HEPES 
    15 mM CaCl2 
    250 mM KCl 
    dissolved in 150 ml H2O, adjust pH to 7.0 with KOH 
    add water to make 200 ml 
    55 mM MnCl2  
    (filtered sterile) 
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4.2.8 Transformation of E.coli cells with plasmid DNA 
Competent bacterial cells were quickly thaw (by hand warming) and 1-2 µl of DNA or 
ligation mixture was added in the suspension and incubated for 30 min on ice. Then 
the cells were subjected to heat shock for 90 sec at 42oC in a water bath, followed by 
a cold shock on ice for 3 min. 800 µl LB medium was added to the cells and 
incubated at 37oC for 1hr to develop the antibiotic resistance. Finally the cells were 
plated on LB-agar plate with appropriate antibiotic. 
4.2.9 Site-directed mutagenesis 
The exchange of one amino acid to another was performed by using synthetic 
oligonucleotides. The plasmid, containing the desired gene, was purified by 
according to protocol mentioned in Macherey Nagel kit. Two designed 
oligonucleotides containing the desired mutation were used to introduce mutation in 
the gene, as described in the scheme (Figure 8). 
 
The protocol used for this mutation is as follows: 
  Plasmid DNA   5-50 ng 
  Primer 1   125 ng 
  Primer 2   125 ng   
  dNTPs       1 µl 
  buffer        5 µl (10x reaction buffer) 
  Pfu turbo polymerase     1 µl (2.5 units/µl) 
  H2O    to add up 50 µl 
 
Then the mixture was placed in an Eppendorf Robocycler with a program as follows: 
  95oC   1 min 
  95oC           30 sec 
  55oC           30 sec           (12-18 cycles)   
  68oC   1 min/kb DNA length 
 
After the reaction the mixture was then cooled on ice for 10 min, thereafter 1 µl Dpn I 
(10 unites/µl) was added in order to cut the parental DNA and incubated for 1 hr in 
37oC. 1-2 µl of the mixture was transformed into DH5α competent cells with 
appropriate antibiotic. The plasmids were isolated from the single colonies as 
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mentioned before with phenol-chloroform treatment. The mutations were identified 
with DNA sequencing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Site-directed mutagenesis. The parental plasmid was purified as described in text. The 
second step consists in the denaturation of the plasmid followed by annealing of two primers, which 
contain the mutation. Next extension of primers by Pfu polymerase (12-18 cycles) incorporates the 
mutation and produces nicked circular strands. In the last step the reaction mixture was incubated at 
37oC for 1 hr with Dpn I, in order to digest the methylated (Gm6A↓TC) nonmutated parental plasmid. 
The mixture was transformed into E.coli DH5α strain, where the nicked circular product would be 
repaired. The mutation was characterized by sequencing as mentioned in the text. This Figure is 
adapted and modified from www.stratagene.com. 
 
4.2.10 Sequencing 
Analysis and identification of cloned PCR-fragments and site-directed mutagenesis 
products were performed (MWG LI-COR 4000L DNA sequencer) by dideoxy chain 
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terminating sequencing using fluorescence labeled (IRD700 or IRD800) primers. The 
sequencing method used is based on cycle PCR method and analysis on LI-COR 
DNA sequencer. The protocol followed is described in the SequiTherm EXCELTM 
DNA sequencing kit. 17 µl of premix was prepared for each DNA template: 
 
Labeled primer   2 pmol 
  DNA          100 - 250 fmol 
  Buffer           7.5 µl (10x stock buffer) 
  DNA polymerase  1 µl 
  Water to add up to           17 µl 
 
Then 2 µl of each termination mix (ddATP, ddCTP, ddGTP and ddTTP) was added in 
four different tubes. 4 µl of premix was added in to each tube and the tubes were 
place into Eppendorf Robocycler with a program: 
  95oC     5 min 
  95oC            30 sec 
  50oC            15 sec    (30 cycles)     
  70oC    1 min 
 
After the PCR 3 µl of stop (loading) buffer was added to each tube, which were 
heated to 95oC for 3-4 min and immediately placed on ice to denature the sample 
before loading. The gel (0.2 cm thick and 66 cm long) was prerun for 10 min before 
loading the 2 µl of sample. The running condition was 2800 V, 40 mA, 55 W, 45oC 
with a scan speed 3 and frame 30. The gel was run for 7-8 hours. The scanned 
bands were analyzed by software (v 4.0 image analysis). 
4.3 Preparative and analytical biochemistry 
4.3.1 Expression and purification of synaptobrevin II in BL21(DE3)pLysS 
Synaptobrevin II was recombinantly expressed in the vector pSNiR. The vector with 
synaptobrevin II gene was transformed into BL21 (DE3) pLysS competent cells and 
plated on a LB-agar plate containing 200 µg/ml ampicillin and 30 µg/ml 
chloramphenicol and incubated overnight at 37oC. One single colony was inoculated 
in 100 ml LB medium (containing 200 µg/ml ampicillin and 30 µg/ml chloramphenicol) 
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and incubated at 37oC until the OD600 was ~ 0.2. Then the bacterial cells were 
induced with 1 mM IPTG and grown further for 3 hrs at 37oC. The cells were then 
harvested and frozen at -20oC. Frozen pellets were resuspended in 4 ml lysis buffer 
(25 mM HEPES pH 7.6; 100 mM NaCl; 1 mM EDTA; 1 mM PMSF; 0.025% [w/v] 
NaN3). The bacterial cell suspension was freezed and thawed three times in liquid N2 
and 37oC. The lysis was performed by the lysozyme expressed from the low copy 
number plasmid pLysS present in the BL21 (DE3) cells. 10 mM MgCl2 was added to 
the lysed suspension to activate the nuclease function of the fusion protein and 
incubated at room temperature 5 min. The suspension was kept on ice (~1hr) for 
complete digestion of DNA. The soluble part was separated from the insoluble part 
of the cell lysate by centrifugation at 14000xg at 4oC for 20 min. The supernatant 
was kept for SDS-PAGE analysis. The pellet was resuspended with solubilization 
buffer (25 mM HEPES pH 7.6; 1 M NaCl; 2% [w/v] Thesit; 1 mM EDTA; 1 mM PMSF; 
0.025% [w/v] NaN3) and incubated at 4oC in an Eppendorf shaker for 1 hr. Non 
solubilized part was separated via ultracentrifugation in Beckman Optima TL at 4oC 
for 1 hr at 100000xg. Finally the supernatant and pellet fractions were visualized by 
Coomassie staining of SDS-PAGE. 
4.3.2 Expression of vacuolar SNARE proteins 
4.3.2.1 Expression of Vam3p, Vti1p, Vam7p and Ykt6  
Vam3p and its mutants, Vti1p and its mutants, Ykt6p and Vam7p were expressed in 
pET28a vector, whereas GST-Ykt6p was expressed in pGEX-4T-1. The respective 
clones were transformed in Rosetta (DE3) competent cells and plated on LB-agar 
plate with kanamycine (35 µg/ml), chloramphenicol (30 µg/ml), and 1% (w/v) glucose 
and incubated at 37oC overnight. A single colony was inoculated into 3 ml LB 
medium (containing kanamycine [35 µg/ml], chloramphenicol [30 µg/ml] and 1% [w/v] 
glucose) and incubated at 37oC overnight. Cells were collected from 1 ml of the 
overnight culture and resuspended with fresh LB medium and inoculated in 1 liter LB 
medium with the antibiotics mentioned before but without glucose. The cells were 
incubated at 37oC until the OD600 reached 0.6-0.8 (~4 hrs) and then cooled on ice 
(for 30-45 min). The cells were then induced with 1 mM IPTG and incubated 
overnight (~20 hrs) at 16oC (at 150 rpm shaking). The cells were harvested, washed 
with PBS and then frozen in -80oC.  
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4.3.2.2 Expression of Nyv1p   
Nyv1p and its mutant, cloned in pET15b, were transformed in Rosetta (DE3) 
competent cells and plated on LB-Agar medium containing ampicillin (50 µg/ml), 
chloramphenicol (30 µg/ml), 1% (w/v) glucose and incubated for overnight at 37oC. A 
single colony was then inoculated in 100 ml LB medium containing ampicillin (200 
µg/ml) and chloramphenicol (30 µg/ml) and incubated at 37oC, until the OD600 
reached 0.5. The cells were induced with 1 mM IPTG and incubated further 3 hrs at 
37oC. Finally the cells were harvested and frozen in -80oC.  Sec17p (pQE9/M15) and 
Sec18p (pQE9/M15) were also expressed by similar procedure. 
4.3.3 Purification of vacuolar SNARE proteins 
The SNARE proteins were expressed with GST-tag or histidine-tag either N-terminal 
or C-terminal. The frozen cells were thawed on ice (10-20 min) and resuspended 
with 20 ml (for 1 liter culture) buffer (25 mM HEPES pH 7.6; 1 M NaCl; 10 mM β-
mercaptoethanol; 2% [v/v] Triton X-100 and 2% [v/v] Thesit, 500 µg α2-
macroglobulin; 20% [v/v] glycerol and lysozyme [5-8 mg]). Cells were kept on ice for 
30 min with occasional mixing by inverting the tube and thereafter sonicated with 7 
sec pulse of 60% amplitude and 20 sec off for 12 min on a Branson digital sonifier 
W-250 D. Prior to sonication 1 mM PMSF was added to the cell suspension. The 
sonication was carried out on ice-cold condition. After sonication 1 mM PMSF and 
500 µg of α2-macroglobulin were added to the mixture again, then 10 mM MgCl2 and 
1 mg DNase I were added and incubated at room temperature (5-10 min). The lysate 
was incubated at 4oC with gentle shaking for maximum solubilization (1-2 hr). The 
soluble proteins were separated from non soluble proteins by centrifugation at 4oC at 
14000Xg for 30 min. The supernatant was applied on a Ni-NTA column or GST 
column. 
4.3.3.1 Purification by immobilized metal ion affinity chromatography (IMAC) 
Two principle buffers were prepared for immobilized metal ion affinity 
chromatography. Buffer A: 25 mM HEPES pH 7.6, 1% Thesit (v/v), 1 M NaCl, 10 mM 
β-mercaptoethanol, 10% glycerol (v/v) and buffer B: 25 mM HEPES pH 7.6, 1% 
Thesit (v/v), 1 M imidazole, 1 M NaCl, 10 mM β-mercaptoethanol, 10% glycerol (v/v). 
The other buffers of different imidazole concentrations (e.g. 50 mM, 80 mM, 100 mM 
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and 500 mM imidazole buffer) were prepared mixing buffer A and B. The HiTrapTM 
Chelating HP column first wash with 5 column volumes of water and then 1 ml of 0.1 
M NiCl2 was applied on the column and washed again with 5 column volumes of 
water. Then the column was equilibrated with 5 column volumes of buffer A at a 
speed of 1 ml/min and then with 5 column volumes of elution buffer (500 mM 
imidazole) and again with 5 column volumes of buffer A. The sample was loaded on 
the equilibrated column at a speed of 0.5 ml/min. After loading the sample, the 
column was washed with imidazole buffer at a speed of 1 ml/min and with a gradient 
from 0–100 mM imidazole. 5 column volumes of each imidazole buffer were used for 
washing the column. The His6-tag protein was eluted with 5 column volumes of 500 
mM imidazole buffer.  The column was washed with 50 mM EDTA for removing 
nickel ions from the column. Eluted fractions were visualized by Coomassie staining 
on SDS-PAGE. 
4.3.3.2 Purification by affinity chromatography on immobilized glutathione 
column 
Two principal buffers were prepared for affinity chromatography on immobilized 
glutathione column – binding buffer (PBS + 1% [v/v] Thesit) and elution buffer (50 
mM Tris pH 8.0, 1 M NaCl, 10 mM reduced glutathione, 1% [v/v] Thesit). The column 
was washed first with water (5 column volumes) and equilibrated at a speed of 1 
ml/min with 5 column volumes of binding buffer, then with 5 column volumes of 
elution buffer and again with 5 column volumes of binding buffer. The sample was 
loaded on the equilibrated column at a speed of 0.5 ml/min. The column was washed 
with 5 column volume of binding buffer with a speed of 1 ml/min. The GST tagged 
protein was then eluted with 5 column volumes of elution buffer. Eluted samples 
were visualized by Coomassie staining on SDS-PAGE. 
4.3.4 Protein storage 
The eluted fractions after purification were dialyzed against buffer containing 25 mM 
HEPES pH 7.6, 1% Thesit (v/v), 1 M NaCl, 10 mM β-mercaptoethanol, 10% glycerol 
(v/v) to remove imidazole or glutathione. Purified SNARE proteins were stored at 4oC 
after dialysis. The dialyzed proteins were further used for protein-protein interaction 
studies. 
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4.3.5 Protein precipitation according to Wessel-Flügge 
The purification according to Wessel-Flügge (Wessel and Flugge, 1984) is based on 
the precipitation of proteins with methanol and subsequent extractions of lipids and 
detergents with chloroform. 400 µl methanol, 300 µl H2O and 100 µl chloroform were 
added to 100 µl of protein solution, mixed by vortexing and centrifuged for 5 min at 
14000xg room temperature. The upper layer was removed carefully and mixed with 
300 µl methanol and centrifuged for 5 min at 14000xg at room temperature. After 
drying the pellet was dissolved in SDS sample buffer. 
4.3.5 Protein precipitation with TCA 
Large volume of protein solution was precipitated with trichloro acetic acid (TCA). 
Equal volume of 20% (w/v) TCA was mixed with protein solution and incubated on 
ice for 30 min. The solution was centrifuged at 4oC at 14000xg for 10 min to collect 
the protein precipitate.  The supernatant was removed and the precipitate was 
washed 3 times with 1 ml of ice-cold acetone. The precipitate was dried and 
resuspended in SDS sample buffer. 
4.3.6 SDS-polyacrylamide gel electrophoresis (Laemmli, 1970) 
SDS-gel electrophoresis allows protein separation according to their molecular 
weights. The anionic detergent SDS denatures the proteins and binds at a ration of 
approximately 1.4 gm SDS per gram of protein, thus conferring a net negative 
charge to the polypeptide in proportion to its length. The separation occurs in an 
electric field. Minigels were run with the Vertical Minigel Unit (Sigma Techware, St. 
Louis. USA). Depending on the molecular weight of the proteins, 7.5–15% 
acrylamide gels were casted as follows (ratio acrylamide: bis-acrylamide 30: 0.8):  
Stacking gel buffer “Upper Tris”: 0.25 M Tris, pH 6.8 0. 0.2% (w/v) SDS 
Separating gel buffer “Lower Tris”: 1 M Tris, pH 8.5, 0.26% (w/v) SDS 
Running buffer: 25 mM Tris pH 8.3, 250 mM glycine, 0.1% (w/v) SDS 
Sample buffer (standard): 50 mM Tris pH 6.8, 3% (w/v) SDS, 10% (v/v) Glycerol, 
0.02% (w/v) bromophenol blue. 
For reducing conditions, 10% (v/v) β-mercaptoethanol or 100 mM DTT were added. 
Protein interaction analysis was done in the presence of only 1% (w/v) SDS 
(ultrapure). Gels were subsequently subjected to Western blot or stained with 
Coomassie brilliant blue. 
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Molecular weight standard     
Low molecular weight markers (LMW): Bovine serum albumin – 66 kDa, ovalbumin – 
45 kDa, glyceraldehyd-3-phosphatedehydrogenase – 36 kDa, carbonic anhydrase – 
29 kDa, trypsinogen – 24 kDa, trypsin inhibitor – 20 kDa, lactalbumin – 14 kDa. 
High molecular weight markers (HMW): Myosin – 205 kDa, β-galactosidase – 116 
kDa, phosphorylase b – 97.4 kDa, bovine serum albumin – 66 kDa,  ovalbumin – 45 
kDa, carbonic anhydrase – 29 kDa. 
4.3.7 Interaction analysis with SDS-PAGE (mild SDS-PAGE or urea SDS-
PAGE) 
Protein-protein interaction studies were carried by mild SDS-PAGE or urea SDS-
PAGE. In mild SDS-PAGE gels were prepared without SDS. Samples were not 
boiled and the SDS concentration in the sample buffer was 2% (w/v). The running 
buffer was Lämmli buffer as described before. Samples were run at 4oC overnight 
(Bowen et al., 2002; Roy et al., 2004). 
 
Alternatively, when urea SDS-PAGE was performed, the gels were made with SDS 
and 6 M urea and they were dissolved in sample buffer containing 1% (w/v) SDS 
plus 6 M urea and samples were not boiled. The SDS concentration in the gel and 
the running buffer was same as Lämmli SDS-PAGE as described before. Samples 
were run at 4oC overnight (Laage and Langosch, 1997; Roy et al., 2004). 
4.3.8 Coomassie staining of proteins 
Coomassie staining is required to visualize proteins separated by SDS-PAGE. The 
gels were incubated for 30 min in Coomassie solution (0.25% [w/v] Coomassie 
brilliant blue [G-250], 50% [v/v] Methanol, 10% [v/v] acetic acid), and destained with 
solution containing 30% (v/v) Methanol, 10% (v/v) acetic acid, until the protein bands 
were visible and the background was fully destained. 
4.3.9 Western Blot 
Antibody detection of electrophoretic separated proteins requires the transfer of the 
proteins from the gel onto a membrane. Separated proteins were blotted with a semi 
dry CTI-blotter for 1 – 2 hr onto nitrocellulose membrane (Amersham Biosciences). 
The gel and nitrocellulose membrane were placed between 5 layers of Whatman 3 
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MM paper soaked in blot buffer (25 mM Tris pH 8.3, 250 mM glycine, 0.1% [w/v] 
SDS, 20 % [v/v] Methanol). Protein bands were visualized in 0.2% (w/v) PonceauS, 
3% (w/v) TCA. Unspecific binding sites were blocked by incubating the blot in TBB 
(5% [w/v] milk powder in TWB) for overnight. The membrane was incubated in 
primary antibody (1:5000 in TBB) for 2 hrs. The blot was washed extensively (20 min 
TBS, 20 min TWB and 20 min TBB) to remove unbound antibody. Blot was then 
incubated with HRP-enzyme coupled secondary antibody (1:50000 in TBB) for 1 hr 
and washed again (20 min TBS, 20 min TWB and 20 min TBS). Finally the blot was 
developed using enhanced chemiluminiscence (ECL). 
TBS: 50 mM Tris-HCl, pH 8.0, 150 mM NaCl 
TWB: 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% Triton X-100 
TBB: 5% non fat dried milk in TWB buffer. 
4.3.9.1 Antibody detection through Enhanced Chemiluminiscence (ECL) 
The ECL method is a very sensitive, non-radioactive and fast method to detect 
antigens on blots. Antigens are directly or indirectly detected with horseradish 
peroxidase (HRP) coupled antibodies. The peroxidase itself reacts with a 
chemiluminiscent substrate and the resulting light signals can be detected via 
autoradiography on ECL films. Development of the blots was done by incubation for 
1 min in ECl-substrate solution that was prepared directly before usage. 
 
ECL-substrate solution: 
Stock solution: 250 mM Luminol (5-amino-2, 3-dihydro-1, 4-phthalazinedione) and 90 
mM p-Coumaric acid (4-hydroxycinnamic acid) solutions were prepared in DMSO 
and aliquots were stored at -20oC. 
Solution A: 50 µl of 250 mM Luminol and 25 µl of 90 mM p-Coumaric acid were 
added to 5 ml of TBS 
Solution B: 3 µl of 30% (w/w) H2O2 was added to 5 ml of TBS solution. 
Solution A and B were mixed in a ratio 1:1 and added on the blot drop by drop to 
cover the total membrane area and incubated for 1min. 
4.3.9.2 Western blot re-probing  
Immobilized proteins on membrane were reprobed with other antibodies by stripping 
the membrane. After developing the membrane with ECL substrate solution, the 
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membrane was stripped with a stripping solution containing 62.5 mM Tris-HCl pH 
6.8, 2% SDS (w/v), 100 mM β-mercaptoethanol. The membrane was soaked into 
stripping solution inside a plastic bag and incubated at 50oC in a water bath with 
occasional shaking for 30 min. The membrane was washed 3 times with TWB buffer. 
Unspecific binding sites were blocked with TBB buffer (5% non fat milk in TBS) 
before incubating with primary and secondary antibody, as described in the previous 
section. Finally the membrane was developed with ECL substrate solution.  
4.3.10 Coupling of IgG to ProteinA-Agarose 
Rabbit polyclonal antisera (1 ml) or affinity purified antibody solutions (rabbit anti 
Vam3p) (10 mg/ml) were loaded onto 500 µl ProteinA-Agarose (Roche) beads, 
which were prewashed with 0.1 M glycine, pH 2.5 and neutralized subsequently with 
0.1 Tris-HCl pH 7.4. Coupling reaction occurred at 4oC on an Eppendorf shaker 
overnight. The beads were washed twice with 10 volume of 0.2 M sodium borate 
buffer pH 9.0 and collected by sedimentation (10 min, 6000xg 4oC in an Eppendorf 
centrifuge). The beads were resuspended in 10 volumes of the same buffer. The 
equivalent of 10 µl beads was removed for the control of coupling reaction efficiency. 
Crosslinking of the antibodies to the beads was done by the addition of solid 
dimethylpimelimidate (DMP) (Perbio Science) to final concentration 20 mM.  
Samples were incubated with gentle shaking for 30 min at room temperature and 
equivalent of 10 µl of the cross-linked beads was removed. The reaction was 
stopped by washing the beads with 0.2 M ethanolamine pH 8.0 and the beads were 
then incubated for 2 hrs at room temperature in 0.2 M ethanolamine on shaker. After 
the final wash beads were resuspended in TBS supplemented with 0.025% NaN3 as 
preservative. The efficiency of the coupling reaction was analyzed with the beads 
taken before and after addition of the cross-linker DMP. Samples were resuspended 
with SDS-PAGE sample buffer and run on 10% SDS-PAGE and subsequently 
stained with Coomassie brilliant blue. 55 kDa heavy chain protein band of the 
antibody was detected by SDS-PAGE when the cross-linker was not added, while 
after addition of the cross-linker this band was not present, thus showing the 
complete antibody cross-linkage with agarose beads. 
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4.3.10.1 Co-immunoprecipitation 
SNARE protein complexes were analyzed by co-immunoprecipitation. The fractions, 
collected from sucrose gradient, were incubated with rabbit anti Vam3p antibody 
coupled with ProteinA-Agarose for 2 hrs or overnight at 4oC. The beads were re-
isolated after brief centrifugation and washed 3 times with buffer containing 25 mM 
HEPES pH 7.6, 1% Thesit (v/v), 1 M NaCl. The bound proteins were eluted with 1 ml 
of 0.1 M glycine pH 2.5, 0.5 % Thesit. Eluted proteins were TCA precipitated for 
further analysis on SDS-PAGE and Western blot. 
4.3.11 Sucrose gradient analysis 
Vacuolar SNARE protein interactions were analyzed on sucrose gradient. A linear 
gradient of 15–60% sucrose was prepared for the analysis. 60% sucrose was 
prepared in a buffer containing 25 mM HEPES pH 7.6, 1 M NaCl, 10 mM β-
mercaptoethanol and 15% sucrose was prepared in buffer containing 25 mM HEPES 
pH 7.6, 1% Thesit (v/v), 1 M NaCl, 10 mM β-mercaptoethanol. In a 4 ml Beckman 
centrifuge tube 3.6 ml of 15% sucrose solution was added and 300 µl 60% sucrose 
solution was put at the bottom of the tube slowly through a syringe. The tube was 
preserved at -20oC or -80oC overnight for complete freezing of the solution. The 
frozen solution was melted (6 – 8 hrs) slowly at 4oC in order to form a linear gradient. 
The single SNARE protein or overnight SNARE protein mixture were added on the 
top carefully and centrifuged for 15 hrs at 4oC at 240,000xg in a SWTi 60 rotor in 
Beckman centrifuge. Twelve fractions were collected from the bottom with a syringe 
and further analyzed by co-immunoprecipitation or TCA precipitation.  
4.3.12 SNARE protein complex assembly 
The SNARE protein assembly was carried out by mixing the equimolar mixture of 
purified SNARE proteins and incubated at 4oC overnight. Complex formation was 
detected by loading the mixture on sucrose gradient after a brief centrifugation.  
4.3.13 SNARE protein complex disassembly  
Overnight SNARE protein mixture (50 µl) was incubated with 10 µg of Sec17p, 10 µg 
Sec18p, 2 mM MgCl2, and 0.5 mM ATP or 0.5 mM ATPγS in a final volume of 100 µl 
for 1 hr at 4oC in an Eppendorf shaker (Horsnell et al., 2002; Sollner et al., 1993a). 
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After a brief centrifugation, the reaction mixture was loaded on sucrose gradient for 
further analysis. 
4.3.14 Protein and peptide estimation 
Protein concentration was estimated by Bradford assay (Bradford, 1976) by using 
BSA as a standard protein. The interference of detergent was corrected by preparing 
the calibration curve with equal amount of Thesit. 
 
Peptides were synthesized by standard solid phase methods (F-moc) by PSL, 
Heidelberg, Germany. Mass spectrometry showed that the peptides were more than 
90% pure. Molar extinction co-efficient of the peptides was determined from the 
software available on website (http://www.basic.nwu.edu/biotools/proteincalc.html). 
Concentration of the peptides was determined with the help of this calculated molar 
extinction coefficient.  
4.3.15 Circular Dichroism spectroscopy 
Linear polarized light can be viewed as a superposition of opposite circular polarized 
light of equal amplitude and phase. A projection of the combined amplitudes 
perpendicular to the propagation of direction thus yields a line (Figure 9 panel A). 
When this light passes through an optically active sample with a different 
absorbance for the two components, the amplitude of the stronger absorbed 
component will be smaller than that of the less absorbed component. The 
consequence is that a projection of the resulting amplitude now yields an ellipse 
instead of the usual line, but the polarization direction has not changed (Figure 9 
panel B). The occurrence of ellipticity is called Circular Dichroism. Rotation of the 
polarization plane (or the axes of the dichroic ellipse) by a small angle α occurs when 
the phases for the 2 circular components become different, which requires a 
difference in the refractive index n. This effect is called circular birefringence.  
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Figure 9. Circular Dichroism (CD) is observed when optically active matter absorbs left and 
right hand circular polarized light slightly differently. A. Linear polarized light can be viewed as a 
superposition of opposite circular polarized light of equal amplitude and phase. B Different absorption 
of the left- and right hand polarized component leads to ellipticity (CD) and optical rotation (OR). The 
actual effect is minute and using actual numbers the ellipse would still resemble a line. This Figure is 
adapted from http://www-structure.llnl.gov/cd/cdtutorial.htm. 
 
CD measurement gives the data recorded as ellipticity θobs in degrees or 
millidegrees. To be able to compare these ellipticity values we need to convert into a 
normalized value. The unit most commonly used in protein and peptide work is the 
mean molar ellipticity per residue. The molar ellipticity or mean residue ellipticity is 
calculated by using the equation presented below: 
 
 
 
Where θobs is the measured ellipticity in degrees, c is the protein concentration in 
mg/ml, l is pathlength in cm, and Mr is the protein molecular weight, NA is the number 
of amino acids per protein, [θ]MRE is the mean residue ellipticity or molar ellipticity. 
(c x l x NA)
[θ]MRE = 
(θobs x 100 x Mr) 
A B
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Mean residue ellipticity have the units degrees X cm2 X dmol-1. The factor 100 in 
equation originates from the conversion of the molar concentration to the dmol/cm3 
concentration unit. Standard curves of different secondary structures of protein are 
presented in Figure 10. 
 
 
 
 
 
 
 
 
Figure 10. Standard curve for different secondary structures of proteins. A, The curve represents 
α-helix when molar ellipticity at 193 nm (π→π*) is positive and negative at 209 nm (π→π*) and 222 
nm (n→π*). The curve represents β-sheet when molar ellipticity is positive at 196 nm (n→π*) but 
negative at 218 nm (π→π*). Molar ellipticity value positive at 212 nm (π→π*) but negative at 195 nm 
(n→π*) indicates the random coil structure of the protein. B, The intensity and energy of these 
transitions depends on Φ and Ψ (i.e., secondary structure). This Figure is adapted from http://www-
structure.llnl.gov/cd/cdtutorial.htm and 
http://www.newark.rutgers.edu/chemistry/grad/chem585/lecture1.html.  
 
All CD spectra were recorded on JASCO J-715 model CD spectrometer with a scan 
speed 50 nm/min and an average of 10-20 scans per sample. The spectra were 
recorded at 20oC. For CD experiment full length proteins were dialyzed in buffer 10 
mM Tris-HCl pH 7.4, 150 mM NaCl and 1% (v/v) Thesit. When peptides were used 
for CD experiments, they were first dissolved in TFE. TFE was evaporated under N2 
and then the peptides resuspended in detergent solution: 10 mM Tris-HCl, pH 6.8 
(for synaptobrevin II) or pH 7.4 (for Vam3p TMD peptides), 1% (v/v) Thesit. 
Synaptobrevin II TMD peptides were resuspended in 6M urea with 10 mM Tris-HCl 
pH 6.8 and 1% (v/v) Thesit for further CD measurement. Samples dissolved in Thesit 
buffer were incubated for 2 hrs to equilibrate. All samples were centrifuged for 30 
Standard curves
Wavelength (nm)
El
lip
tic
ity
80000
60000
40000
20000
0
-20000
-40000
190 210 230 250
Helix
Sheet
Coil
A
B
 
Rana Roy Materials and Methods 46 
min at 14000xg before recording spectra. CD measurements were done at a 
concentration ~0.100mg/ml and with 0.1 cm path length quartz cuvette. The 
spectrum of the synaptobrevin II peptide dissolved in 6M urea was measured at a 
concentration of ~0.500 mg/ml and with 0.02 cm path length cuvette. Similar data 
were obtained when CD spectra in the absence or presence of urea were recorded 
at the same peptide concentration (~0.100mg/ml) (Roy et al., 2004). Molar ellipticity 
of the spectra were calculated by using the formula mentioned above and those 
were fitted using standard software CDNN ((Bohm et al., 1992), 
http://www.imtech.res.in/pub/pspt/cdnn/win/) and the average secondary structures 
were calculated.        
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5 Results 
5.1 Expression and purification of SNARE protein 
To understand the role of TMD in SNARE protein interaction the wild type proteins 
and its mutants were expressed recombinantly in E.coli. This will provide good 
amount of proteins for the further experiments. The details of protein expression and 
purification are discussed in this section. 
5.1.1 Expression and purification of synaptobrevin II 
Synaptobrevin II is a v-SNARE or R-SNARE protein, of synaptic vesicles. Previous 
studies from our laboratory showed that synaptobrevin II has two interaction domains 
– cytosolic domain and C-terminal transmembrane domain (TMD) (Laage and 
Langosch, 1997). In this study synaptobrevin II was cloned in pSNiR2 under T7 
promoter and expressed in E.coli BL21(DE3)pLysS, as described in methods (Laage 
and Langosch, 1997; Laage and Langosch, 2001; Roy et al., 2004). Figure 11 shows 
the expression and purification of synaptobrevin II as nucleaseA fusion protein.  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Expression and purification of synaptobrevin II. Proteins were visualized by Coomassie 
staining in 12.5% SDS-PAGE. Lane UI represents the total protein from uninduced host cells, lane I 
represents the total protein from induced host cells, lane S represents the soluble protein fraction 
obtained after cell lysis, and lane M represents the detergent soluble protein fraction from membrane 
and other insoluble material obtained from the host cell after cell lysis. In the M fraction the arrow 
shows the enriched nucleaseA synaptobrevin II fusion protein. 
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5.2 Expression and purification of yeast vacuolar SNARE proteins 
Yeast vacuole membrane fusion is a homotypic fusion in which five SNARE proteins 
Vam3p, Nyv1p, Vam7p, Vti1p and Ykt6p are involved. The corresponding genes 
were directly amplified from yeast genome and cloned into different expression 
vectors in E.coli, therefore the codons of these genes are not optimized for E.coli 
expression host. In order to clarify the possibility of the expression of these 
eukaryotic genes in E.coli host, the codon degeneracy of the amino acids of these 
proteins was analyzed with the software available on internet (E.coli codon usage 
analyzer 2.1 http://faculty.ucr.edu/~mmaduro/codonusage/usage.htm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Analysis of codon by E.coli codon analyzer 2.1. The codon analyzer shows the 
percentage of the codons that can not be translated in E.coli host. Yeast vacuole SNARE proteins 
have on average 20-30% codons that can not be translated in E.coli.  
 
Codon degeneracy analysis (Figure 12) shows that the vacuolar SNARE proteins 
contain certain percentage of codons, which can not be translated efficiently, due to 
the low frequency of the corresponding tRNAs in E.coli. Therefore a special host 
strain Rosetta(DE3) was used for the expression of these yeast proteins in 
prokaryote. Rosetta host strains are BL21 derivatives, designed to enhance the 
expression of eukaryotic proteins that contain codons rarely used in E. coli. These 
strains supply tRNA genes for AGG (Arg), AGA (Arg), AUA (Val), CUA (Leu), CCC 
(Pro), GGA (Gly) on a Col-E1 compatible chloramphenicol-resistant plasmid. Thus 
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the Rosetta strains provide for "universal" translation, which is otherwise limited by 
the codon usage of E. coli. Transcription of the tRNA genes is driven by their native 
promoters.   
 
The use of this strain did not solve the entire problem of expression, e.g., Vam3p did 
not express at all when induction was done at 37oC, whereas good yield of proteins 
was obtained in cold condition at 16oC. In case of Vam7p, expression and induction 
at 37oC gave low amount of protein; moreover a ladder of low molecular weight 
proteins was visible, thus suggesting degradation or truncation of the protein during 
synthesis. Vam7p and Vti1p expression and induction in cold condition at 16oC gave 
good amount of proteins. For yeast protein expression in prokaryotic host, the cold 
condition increased the stability of the protein as shown for other proteins (Brugger 
et al., 2000; Mujacic et al., 1999; Qing et al., 2004).  
 
Different studies report that expression of membrane proteins or eukaryotic proteins 
in E.coli host cells can lead to the production of insoluble inclusion bodies, in which 
the foreign protein is not in the native folding state. To overcome this problem, the 
above mentioned proteins were expressed and induced in cold condition at 16oC; in 
particular the cells were first grown at 37oC till the OD600 was about 0.5 and then 
incubated on ice to cool down the temperature of the culture (as described in method 
section and Figure 13). Induction was done by adding IPTG to the cold cultures and 
cells were grown further for expression of the desired protein at 16oC. It has been 
shown that temperature changes can induce in the bacterial cells the production of 
cold shock proteins, which can act as chaperons for protein folding (Dougan et al., 
2002; Hartl and Hayer-Hartl, 2002; Walter and Buchner, 2002; Wegele et al., 2004).  
 
After obtaining good expression the next task was to purify the proteins. Proteolysis 
of the proteins was avoided by using a combination of protease inhibitor: PMSF, α2-
macroglobulin and EDTA free protease inhibitor cocktail tablets (Roche). The 
conventional membrane protein purification protocol is commonly based on two 
sequential steps:  cell lysis followed by separation of soluble part from insoluble part, 
where in this last step the membrane proteins are solubilized from the insoluble part 
in presence of detergent. Here we introduced few modifications (Figure 13) in order 
to avoid proteolysis and to improve membrane protein solubilization. In particular we 
Rana Roy Results: Expression and Purification 50 
lysed the bacterial cells in the presence of 2% Triton X-100 (v/v) and 2% Thesit (v/v) 
with HEPES buffer and 1 M NaCl, thus allowing complete solubilization of the 
membrane fraction under the optimal conditions (pH, detergent and salt) for the 
stabilization of vacuolar SNARE proteins. The lysate was applied on column for 
purification. The expression and purification of each vacuolar SNARE proteins are 
discussed below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Schematic representation yeast SNARE protein expression in E.coli. Protein was 
produced following either pathway A or B as mentioned in the method section.    
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5.2.1 Expression and purification of Vam3p and the its mutants 
Vam3p is a Q-SNARE that participates in the yeast vacuolar membrane fusion. This 
protein contains a single membrane spanning domain. Previous studies from our 
laboratory showed that TMD of Vam3p is very important for vacuolar membrane 
fusion, since deletion of its TMD reduces the efficiency of vacuolar membrane fusion 
(Rohde et al., 2003). Vam3p was cloned in pET28a under T7 promoter. The mutants 
Vam3p∆TMD (amino acid residues 1–263) and Vam3p Ala20 (amino acid residues 
264–283 were changed to alanine stretch) (Figure14, panel H) were produced by 
PCR and cloned in the same vector between the NcoI and XhoI sites, like the wild 
type Vam3p. The mutant Vam3pC274A was prepared by site-directed mutagenesis, 
as described in the methods section. Mutations were confirmed by sequencing. All 
these mutants have a C-terminal (His)6-tag for purification. The Vam3p TMD mutants 
Vam3pA4 (where amino acid residues 265, 269, 273 and 277 were mutated to 
alanine) and Vam3pA4bb (where amino acid residues 267, 271, 275 and 279 were 
mutated to alanine) are cloned between the BamHI and XhoI sites of the same 
vector (Figure14, panel H). These two mutants have an N-terminal (His)6-tag for 
purification. Expression of these proteins was carried out in cold condition (16oC) for 
20 hours. Vam3p and its mutants were purified by Ni-NTA column, as described in 
the methods section.  After purification the purified proteins were visualized by 
Coomassie staining on SDS-PAGE (Figure 14).  The purified proteins were dialyzed 
to remove imidazole (Figure14, panel G) and the dialyzed proteins were stored at 
4oC for further usage. 
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Figure 14. Expression and purification of Vam3p and its mutants. Proteins were visualized by 
Coomassie staining in 12.5% SDS-PAGE. A, Vam3p; B, Vam3p∆TMD; C, Vam3pAla20; D, Vam3pA4; 
E, Vam3pA4bb; F, Vam3pC274A; G, dialyzed Vam3p and its mutants; H, sequence of the Vam3p wild 
type TMD and its mutants. Lane UI represents the total proteins of the uninduced host cells, lane I 
represents the total proteins of the induced host cells, lane 1 represents the first fraction of the purified 
protein from the column, lane 2 represents the second fraction of the purified protein from the column, 
lane 3 represents the third fraction of the purified protein from the column. Proteins were eluted with 
500 mM imidazole concentration. Arrows indicate the enriched protein fraction of Vam3p and its 
mutants. 
 
5.2.2 Expression and purification of Nyv1p and mutants 
Nyv1p is an R-SNARE, participating in the vacuolar membrane fusion. This protein 
contains a single membrane spanning domain. Nyv1p was cloned in pET15b under 
T7 promoter between the NdeI and BamHI sites. The mutants Nyv1p∆TM (amino 
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acid residues 1–226) and Nyv1pAla21 (amino acids residues 229–249 were 
changed to alanine stretch) (Figure 15, panel E) were prepared by PCR, cloned in 
the same vector between the same restriction sites as the wild type. Mutations were 
confirmed by sequencing. All these proteins contain N-terminal (His)6-tag for 
purification by Ni-NTA column. Nyv1p and its mutants were induced and expressed 
at 37oC for 3 hours, as described in the methods section. Purified proteins were 
visualized by Coomassie staining in SDS-PAGE (Figure 15). The purified proteins 
were dialyzed to remove imidazole (Figure 15, panel D) and the dialyzed proteins 
were stored at 4oC for further usage. 
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Figure 15. Expression and purification of Nyv1p and its mutants. Proteins were visualized by 
Coomassie staining in 12.5% SDS-PAGE. A, Nyv1p; B, Nyv1p∆TMD; C, Nyv1pAla21; D, dialyzed 
Nyv1p and its mutants; E, sequence of wild type Nyv1p and its mutants. Lane UI represents the total 
proteins of the uninduced host cells, lane I represents the total proteins of the induced host cells, lane 
1 represents the first fraction of the purified protein from the column, lane 2 represents the second 
fraction of the purified protein from the column, lane 3 represents the third fraction of the purified 
protein from the column. Proteins were eluted with 500 mM imidazole concentration. Arrows indicate 
the enriched protein fraction of Nyv1p and its mutants. 
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5.2.3 Expression and purification Vti1p and mutants 
Vti1p is a Q-SNARE with a single membrane spanning domain. This protein was 
cloned into pET28a under T7 promoter between the BamHI and EcoRI sites. The 
mutants Vti1p∆TM (amino acid residues 1–188) and Vti1pAla23 (amino acid 
residues 190–212 were changed to alanine stretch) (Figure 16, panel E) were 
prepared by PCR and cloned into same vector between the same restriction sites as 
the wild type. The mutations were characterized by sequencing. These proteins were 
cloned with N-terminal (His)6-tag for purification by Ni-NTA column. Expression and 
induction was done in cold condition at 16oC for 20 hours. Purified proteins were 
visualized by Coomassie staining upon SDS-PAGE (Figure 16). The purified proteins 
were dialyzed to remove imidazole (Figure 16, panel D) and the dialyzed proteins 
were preserved at 4oC for further usage. 
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Figure 16. Expression and purification of Vti1p and its mutants. Proteins were visualized by 
Coomassie staining in 12.5% SDS-PAGE. A, Vti1p; B, Vti1p∆TMD; C, Vti1pAla23; D, dialyzed Vti1p 
and its mutants; E, sequence of Vti1p and its mutants. Lane UI represents the total proteins of the 
uninduced host cells, lane I represents the total proteins of the induced host cells, lane 1 represents 
the first fraction of the purified protein from the column, lane 2 represents the second fraction of the 
purified protein from the column, lane 3 represents the third fraction of the purified protein from the 
column. Proteins were eluted with 500 mM imidazole concentration. Arrows indicate the enriched 
protein fraction of Vti1p and its mutants. 
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5.2.4 Expression and purification of Vam7p 
Vam7p is a Q-SNARE that does not contain any membrane spanning domain. It is 
localized in vacuolar membrane as well as in cytoplasm. This protein was cloned into 
pET28a under T7 promoter between the BamHI and EcoRI sites. It was expressed 
and induced in cold condition at 16oC. Vam7p was expressed with N-terminal (His)6-
tag for purification by Ni-NTA column. The purified protein was visualized by 
Coomassie staining in SDS-PAGE (Figure 17). The purified protein was dialyzed to 
remove imidazole (Figure 17, panel B) and stored at 4oC for further usage. 
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Figure 17. Expression and purification of Vam7p. Proteins were visualized by Coomassie staining 
in 12.5% SDS-PAGE. A, Lane UI represents the total proteins of the uninduced host cells, lane I 
represents the total proteins of the induced host cells, lane 1 represents the first fraction of the purified 
protein from the column, lane 2 represents the second fraction of the purified protein from the column, 
lane 3 represents the third fraction of the purified protein from the column. Proteins were eluted with 
500 mM imidazole concentration. B, dialyzed Vam7p. Arrows indicate the enriched protein fraction of 
Vam7p.  
 
5.2.5 Expression and purification of Ykt6p 
Ykt6p is an R-SNARE in vacuolar membrane fusion and it does not contain any 
membrane spanning domain. It is attached to membrane by prenylation at the C-
terminus. This protein was obtained in pGEX 4T-1 vector under tac promoter 
between the BamHI and XhoI sites. Ykt6p was expressed and purified as a GST 
fusion protein (Figure 18, panel A). The same Ykt6p gene was again subcloned in 
pET 28a under T7 promoter between the BamHI and XhoI sites, expressed with N-
terminal (His)6-tag for purification and purified by Ni-NTA column (Figure 18, panel 
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C). The purified proteins were dialyzed to remove imidazole and glutathione (Figure 
18, panels B & D) and was stored at 4oC for further usage. 
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Figure 18. Expression and purification of Ykt6p. Proteins were visualized by Coomassie staining 
upon 12.5% SDS-PAGE. A, GST-Ykt6p; B, dialyzed GST-Ykt6p; C, His6-tagged Ykt6p; D, dialyzed 
His6-Ykt6p. Lane UI represents the total proteins of the uninduced host cells, lane I represents the 
total proteins of the induced host cells, lane 1 represents the first fraction of the purified protein from 
the column, lane 2 represents the second fraction of the purified protein from the column, lane 3 
represents the third fraction of the purified protein from the column, lane 4 represents the fourth 
fraction of the purified protein from the column. Proteins were eluted with 500 mM imidazole 
concentration or 10 mM reduced glutathione concentration. Arrows indicate the enriched protein 
fraction of Ykt6p. 
 
5.2.6 Expression and purification of Sec17p and Sec18p 
Sec17p and Sec18p are α-SNAP and NSF homologous of yeast respectively. These 
proteins were cloned into vector pQE9 under T5 promoter. Both proteins were 
expressed in M15 E.coli host cells and were induced at 37oC. (His)6-tag purified 
proteins were visualized by Coomassie staining in SDS-PAGE (Figure 19 panel A & 
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C). The purified proteins were dialyzed to remove imidazole (Figure 19 panel B & C) 
and the dialyzed proteins were stored at 4oC for further usage. 
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Figure 19. Expression and purification of Sec17p and Sec18p. Proteins were visualized by 
Coomassie staining in 12.5% SDS-PAGE. A, Sec18p; B, dialyzed Sec18p; C, Sec17p; D, dialyzed 
Sec17p. Lane UI represents the total proteins of the uninduced host cells, lane I represents the total 
proteins of the induced host cells, lane 1 represents the first fraction of the purified protein from the 
column, lane 2 represents the second fraction of the purified protein from the column, lane 3 
represents the third fraction of the purified protein from the column. Proteins were eluted with 500 mM 
imidazole concentration. Arrows indicate the enriched protein fraction of Sec17p and Sec18p. 
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5.2.7 Storage and stability of vacuolar SNARE proteins 
After obtaining good expression of vacuolar SNARE proteins, another task was 
optimizing the stability and storage of these proteins. It was not possible to store 
these proteins at -80oC, due to their insolubility when thawed from -80oC, therefore 
these proteins were stored at 4oC. Different detergents were used for solubilizing the 
vacuolar proteins as shown in Table 1. In particular Nyv1p and its mutants are stable 
only in HEPES buffer with Thesit, whereas in Triton X-100 and CHAPS oligomers 
are formed, as determined by sucrose gradient separation (data not shown). 
Particularly when Nyv1p was solubilized in phosphate buffer with Triton X-100, the 
protein showed very high oligomer in sucrose gradient (data not shown). Ykt6p 
without any soluble tag is forming unspecific aggregates, as demonstrated by 
sucrose gradient separation, in which the protein is present in the entire twelve 
fractions collected (Figure 30). In case of Vti1p and its mutants solubilization with 
Triton X-100 or CHAPS is at first successful, but after one week of storage the 
proteins were precipitated. Moreover, Vam7p and Vti1p were stable only in the 
presence of 1 M NaCl; therefore all the proteins were stored in 1 M NaCl for 
uniformity.  
 
In summary, vacuolar SNARE proteins were stored in buffer containing 25 mM 
HEPES pH 7.6, 1 M NaCl, 10 mM β-mercaptoethanol as reducing agent, 1% (v/v) 
Thesit as detergent and 10% (v/v) glycerol at 4oC.  
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Table 1: Stability of vacuolar SNARE protein in different detergent 
 
 Detergent  
Protein Thesit Triton X-100 CHAPS 
Vam3p stable stable stable 
Vam3p∆TMD stable stable stable 
Vam3pAla20 stable stable stable 
vam3A4 stable visible precipitation stable 
vam3A4bb stable visible precipitation stable 
Vam3pC274A stable stable stable 
Nyv1p stable aggregation1 aggregation 
Nyv1p∆TMD stable aggregation aggregation 
Nyv1p Ala21 stable aggregation aggregation 
Vti1p stable visible precipitation visible precipitation 
Vti1p∆TMD stable visible precipitation visible precipitation 
Vti1p Ala23 stable visible precipitation visible precipitation 
Vam7p stable stable stable 
His-ykt6 aggregation aggregation aggregation 
GST-ykt6 stable stable stable 
1aggregation as detected by sucrose gradient centrifugation.  
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5.3 Structural analysis of SNARE proteins 
Previous studies on neuronal and endosomal SNAREs, revealed a high α-helical 
conformation of proteins in the complex. Moreover the crystal structure of neuronal 
SNARE complex demonstrated a typical coiled-coil pattern of interaction of the 
SNARE domains (Antonin et al., 2002; Sutton et al., 1998). The Secondary structure 
of vacuolar SNARE proteins, its mutants and the corresponding TMD peptides was 
examined by CD spectroscopy to understand how deletion of TMD or mutation in 
TMD influences the structure of the full length protein. CD spectroscopy 
measurement and calculations of secondary structure were carried out as described 
in methods section.  
5.3.1 Secondary structural analysis of synaptobrevin II TMD peptide 
As shown in the next chapter synaptobrevin II exists as monomer and dimer, as 
detected especially in the presence of urea SDS-PAGE (Laage and Langosch, 1997; 
Roy et al., 2004). Because urea normally denatures proteins, we tested whether it 
influences the secondary structure of synaptobrevin II TMD in the detergent solution 
with and without 6 M urea or TFE (Figure 20). The calculated secondary structure of 
synaptobrevin II TMD (Table 2) shows higher α-helical content in TFE than in 
detergent solution or in detergent solution with 6 M urea. The α-helical content of the 
peptide in detergent solution with or without 6 M urea is almost similar; showing that 
synaptobrevin II TMD can preserve its secondary structure in 6 M urea.   
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Figure 20. CD spectra analysis of synaptobrevin II TMD peptide. The synaptobrevin II TMD 
peptide was first dissolved in TFE and then different portions were dried under N2 gas and 
resuspended in buffer containing 10 mM Tris-HCl, pH 6.8, 1% (v/v) Thesit with and without 6 M urea. 
Spectra were recorded from 180-260 nm (TFE), 193-260 nm (Thesit without urea) and 205-260 nm 
(Thesit with 6 M urea). The downward deflection of the spectra below 200 nm for peptides in Thesit is 
an artifact due to high optical density of the sample in this region.   
 
Table 2: Spectral analysis of synaptobrevin II TMD peptide 
Calculation was carried out from the spectra obtained between 205-260 nm to treat all the data 
equally. In the Table percentage of α-helix and β-sheet content were presented and residual 
secondary structure were accounted by random coil and β-turn conformations. 
 
 Secondary structure 
Solvent %of α-helix % of β-sheet 
TFE 85 2 
1% Thesit without urea 69 6 
1% Thesit with 6M urea 65 7 
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5.3.2 Secondary structure of Vam3p recombinant proteins and synthetic 
TMD peptides 
Before CD analysis, these proteins were dialyzed against buffer containing 10 mM 
Tris-HCl, pH 7.4, 150 mM NaCl and 1% (v/v) Thesit in order to stabilize them in 
solution. After dialysis, proteins were centrifuged briefly before performing CD 
spectroscopy experiment. Figure 21 shows the different spectra of Vam3p and its 
mutants. In Figure 21, panel A the spectra of full length Vam3p and its mutants are 
shown for comparison. Wild type and mutant proteins show similar spectra, 
suggesting similar secondary structure, confirmed by calculation of the secondary 
structure percentage (Table 3). Results obtained show that recombinantly expressed 
Vam3p is mainly in α-helical conformation and mutation in TMD did not destabilize 
the helical property of the protein. Secondary structure of the Vam3p wild TMD 
peptide and its TMD mutant peptides was also determined to understand the effect 
of mutations on the TMD structure. CD spectra of Vam3p wild type TMD (Figure 21, 
panel B), Vam3pA4 (Figure 21, panel C) and Vam3pA4bb (Figure 21, panel D) 
peptides were determined in TFE and in detergent solution. Figure 21, panel E 
shows the molar ellipticity of Vam3p TMD peptide and its mutant in 1% (v/v) Thesit 
while Figure 21, panel F shows the same in TFE  for better comparison. The TMD 
peptides showed stronger α-helical properties in TFE than in detergent solutions 
(Table 3). Calculated results show that in detergent solution Vam3pA4bb lose α-
helical content with increased percentage of the β-sheet content, while all the other 
peptides in the detergent solution retained high amount of α-helical structure and 
negligible amount of β-sheet structure.  
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Figure 21. CD spectra of Vam3p and mutants. A. Recombinant purified proteins were dialyzed 
against 10 mM Tris-HCl, pH 7.4 150 mM NaCl, 1% (v/v) Thesit before CD analysis. The spectra were 
measured between 200-260 nm. B, Vam3p wild type TMD synthetic peptide 
(KKKWVTLIIIIVVCMVVLLKKK); C, Vam3pA4 TMD synthetic peptide (KKKWATLIAIIVACMVALLKKK) 
and D, Vam3pA4bb TMD synthetic peptide (KKKWVTAIIIAVVCAVVLAKKK). CD spectra were 
recorded in TFE and in 10 mM Tris-HCl pH 7.4, 1% (v/v) Thesit solution; E, molar ellipticity of Vam3p 
TMD synthetic peptides and its mutant in 10 mM Tris-HCl, pH 7.4 1% Thesit (v/v). F, molar ellipticity 
of Vam3p TMD synthetic peptide and its mutant in 100% TFE. The spectra were measured between 
185-260 nm.  
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Table 3 CD spectral analysis of Vam3p full length protein and TMD peptides 
Calculations were carried out using the spectra obtained between 200-260 nm to treat all the data set 
equally. Full length Vam3p protein is mostly α-helical. Buffer represents 10 mM Tris-HCl, pH 7.4, 150 
mM NaCl, 1% (v/v) Thesit (for peptides 150 mM NaCl is omitted). In the Table percentage of α-helix 
and β-sheet content are presented and residual secondary structure was accounted by random coil 
and β-turn conformations. 
 
 Secondary structure 
Protein/peptide Solvent %of α-helix % of β-sheet 
Vam3p (full length) buffer 81 3 
Vam3p∆TMD (full length) buffer 78 3 
Vam3pAla20 (full length) buffer 78 3 
Vam3pA4 (full length) buffer 80 3 
Vam3pA4bb (full length) buffer 81 3 
Vam3p 16 (TMD peptide) TFE 81 3 
Vam3p 16 (TMD peptide) buffer 59 8 
Vam3p 16 A4 (TMD peptide) TFE 82 2 
Vam3p 16 A4 (TMD peptide) buffer 68 6 
Vam3p 16 A4bb (TMD peptide) TFE 80 3 
Vam3p 16 A4bb (TMD peptide) buffer 39 14 
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5.3.4 Secondary structural analysis of Nyv1p 
In Figure 22 CD spectra analysis shows that Nyv1p and its mutants are highly α-
helical. Secondary structure calculations show (Table 4) that deletion or mutation in 
TMD does not modify the α-helix content. 
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Figure 22. CD spectral analysis Nyv1p and mutants. The spectra were measured between 200-260 
nm as described in Figure 21.  
 
Table 4 CD spectral analysis of Nyv1p full length protein and TMD mutant 
Calculations were carried out from the data obtained between 200-260 nm as described in Table 3 
 
 Secondary Structure 
Protein Solvent %of α-helix % of β-sheet 
Nyv1p (full length) buffer 83 2 
Nyv1p∆TMD (full length) buffer 78 3 
Nyv1p Ala21 (full length) buffer 83 2 
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5.3.5 Secondary structure analysis Vti1p 
Figure 23 shows that Vti1p proteins have a high amount of α-helical structure. 
Secondary structure calculations show (Table 5) that deletion or mutation in TMD 
has no effect on the percentage of α-helix content. 
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Figure 23. CD spectral analysis Vti1p and mutants. The spectra were measured between 200-260 
nm as described in Figure 21.  
 
Table 5 CD spectral analysis of Vti1p full length protein and TMD mutants 
Calculations were carried out from the spectra obtained between 200-260 nm as in Table 3 
 
 Secondary Structure 
Protein Solvent %of α-helix % of β-sheet 
Vti1p (full length) buffer 85 2 
Vti1p∆TMD (full length) buffer 84 2 
Vti1p Ala23 (full length) buffer 83 2 
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5.3.6 Secondary structure analysis of Vam7p and Ykt6p 
CD spectra of Vam7p and Ykt6p were shown in Figure 24. Figure 24, panel A shows 
that the full length Vam7p is highly α-helical, while Ykt6p (Figure 24, panel B) has the 
lowest α-helical content and the highest percentage of β-sheet content of all vacuolar 
SNARE proteins tested here (Table 6).  
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Figure 24. CD spectral analysis Vam7p and Ykt6p. The spectra were measured between 200-260 
nm as described in Figure 21. A Vam7p showed typical α-helical property. B Ykt6p revealed different 
amount of α-helical and β-sheet structure. 
 
Table 6 CD spectral analysis of Vam7p and Ykt6p full length protein 
Calculations were carried out from the spectra obtained between 200-260 nm as described in Table 3  
 
 Secondary Structure 
Protein Solvent %of α-helix % of β-sheet 
Vam7p (full length) buffer 86 2 
Ykt6 (full length) buffer 53 10 
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5.4 Self-interaction of SNARE proteins 
SNARE proteins mediate membrane fusion of vesicles to target membranes (Sollner 
et al., 1993a; Sollner et al., 1993b). The homotypic yeast vacuole fusion is 
dependent on the transition from the cis-complex, made by SNARE proteins, on the 
same membrane, to the trans-complex, where the SNARE proteins from opposing 
membranes interact (Figure 2 in introduction) (Jahn, 1999; Jahn, 2000; Jahn, 2004; 
Jahn et al., 2003; Jahn and Sudhof, 1999; Mayer, 2002; Mayer et al., 1996; Wickner, 
2002). The stability of the cis-complex may be one parameter that regulates SNARE 
function. In light of the functional significance of the TMD (Rohde, 2002; Rohde et 
al., 2003) its role in homophilic interaction and SNARE complex formation was 
studied.  
5.4.1 Homo-oligomerization of synaptobrevin II 
Previous studies from our laboratory showed that synaptobrevin homodimerization is 
mediated by the TMD, as its cytoplasmic domain does not show any dimerization 
(Laage and Langosch, 1997). Self-interaction of recombinant synaptobrevin II was 
analyzed by: 
1. “mild” SDS-PAGE, without urea, in which low SDS concentration were 
used to preserve protein-protein interaction and sample boiling was 
omitted (Figure 25, panel A), 
2. “urea” SDS-PAGE, in presence of 6M urea (Figure 25, panel B), since it is 
known that urea decreases the unspecific aggregation of membrane 
proteins in SDS-PAGE (Soulie et al., 1996). 
The results obtained, (Figure 25) showed that the dimer is far less stable in “mild” 
SDS-PAGE than in urea. In the absence of urea the dimer was barely visible and 
only at higher concentration of synaptobrevin II, whereas it was prominent in urea 
SDS-PAGE. As shown in the previous section, the secondary structure of the 
synaptobrevin II TMD is not affected by 6 M urea, as determined by CD spectra 
analysis. Therefore urea affects protein-protein interaction rather than secondary 
structure formation.    
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Figure 25. Dimerization of solubilized recombinant synaptobrevin II. Synaptobrevin II fusion 
protein homodimerization was analyzed by SDS-PAGE. In panel A, the protein was dissolved in 
sample buffer with 2% (w/v) SDS at the indicated concentrations and incubated at 37 °C as in Bowen 
et al. (Bowen et al., 2002) prior to electrophoresis in a gel without urea. In panel B, the protein was 
dissolved in sample buffer with 1% (w/v) SDS plus 6 M urea at a concentration of 30 µM and 
electrophoresed at 4 °C in a gel containing 6 M urea as described by Laage et al. (Laage and 
Langosch, 1997). Significant homodimer is visible only in the presence of urea. 
 
5.5 Homo interaction of vacuolar SNARE proteins 
To characterize homophilic interactions of vacuolar SNARE proteins, SDS-PAGE in 
mild condition and urea SDS-PAGE, were also tried. Unfortunately it was not 
possible to clearly detect homodimers in these cases (data not shown). Probably 
vacuolar SNARE proteins homophilic interactions are too unstable under denaturing 
conditions, even at very low SDS concentration, at which most of neuronal SNARE 
homophilic interactions are stable. Therefore methods were used, where native 
conditions are preserved. In particular homophilic interactions of vacuolar SNARE 
proteins (Vam3p, Nyv1p, Vti1p, Vam7p and Ykt6p) were studied by sucrose gradient 
at non-denaturing conditions.  
5.5.1 Homo oligomerization of Vam3p and its TMD mutants 
Vam3p is a Q-SNARE protein. For better understanding of the involvement of the 
TMD in self-interaction of Vam3p, the mutants Vam3pA4 and Vam3pA4bb were 
produced. Vam3pA4 is a mutant in which four important amino acids (residues 265, 
269, 273 and 277) were mutated to alanine, whereas in Vam3pA4bb four amino 
acids (residues 267, 271, 275 and 279) at the opposite side of the helix were 
mutated to alanine (Figure 14, panel H & Figure 26, panel B). The gap of four 
residues was chosen because 3.6 amino acid residues make one helix turn. Another 
Rana Roy Results: Self-interaction of SNARE proteins 70 
Vam3p TMD mutant was produced, in which the cysteine residue at position 274 is 
mutated to alanine, (Figure 14, panel H) by site-directed mutagenesis. The other 
mutant Vam3p∆TMD, that represents the cytoplasmic domain (amino acid residues 
1–263), was produced to analyze the self-interaction of Vam3p without TMD. In the 
Vam3pAla20 mutant, the TMD is replaced by a stretch of 20 alanines (amino acid 
residues 264–283). Sucrose gradient analysis of Vam3p and the series of its TMD 
mutants shows that Vam3p is mostly in dimer form (Figure 26 panel A), since the 36 
kDa protein co-migrates with the 66 kDa BSA, used as marker in a parallel gradient. 
Dimerization is not an artifact of disulfide bridge formation between cysteine 274, 
since Vam3pC274A, where the cysteine at 274 position is replaced by alanine, is 
also dimer. Interestingly the mutant Vam3p∆TMD and vam3A4 are mostly monomer 
in sucrose gradient. Vam3pA4bb and Vam3pAla20 are in equilibrium between 
monomer and dimer forms in sucrose gradient. The results show that dimerization of 
Vam3p is mediated by TMD. It was surprising to find that mutating both putative 
helix-helix interfaces abolished dimerization. This will be discussed below in the light 
of the findings on secondary structure described in the previous section.  
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Figure 26. Self-interaction of Vam3p and its TMD mutants. A Vam3p analysed in 15-60% linear 
sucrose gradient. Sucrose gradient was prepared in 25 mM HEPES pH 7.6, 1 M NaCl, 10 mM β-
mercaptoethanol and 1% (v/v) Thesit. Fractions were collected from the bottom to top. Molecular 
weight estimation was done by loading single protein markers on the sucrose gradient in same 
condition. B schematic representation of interaction interface of Vam3p TMD. As shown the sequence 
in Figure 14, the gap of two amino acid residue between Vam3pA4 and Vam3pA4bb leads the 
mutation in the back side of the helix in case of Vam3pA4bb.     
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5.5.2 Homooligomerization of Nyv1p and its TMD mutants 
Nyv1p is an R-SNARE protein. The two mutants Nyv1p∆TMD (amino acid residues 
1–226), lacking the full TMD and Nyv1pAla21, in which the TMD is replaced by oligo 
alanine (amino acid residues 229–250) were produced. These mutants were created 
to study the self-interaction of Nyv1p without TMD and with altered TMD sequence. 
Self-interaction of Nyv1p and its TMD mutants were studied by sucrose gradient. 
The results obtained (Figure 27) show that Nyv1p (34 kDa) and Nyv1p∆TMD are 
present as monomer and possibly accompanied by a small amount of dimer, 
whereas for Nyv1pAla21 the equilibrium seems to be shifted to the monomer form. 
From this result it seems that Nyv1p homooligomerization is not mediated by TMD. 
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Figure 27. Self-interaction of Nyv1p and its TMD mutants.  Nyv1p analyzed in 15-60% linear 
sucrose gradient. Sucrose gradient was prepared in 25 mM HEPES, pH 7.6, 1 M NaCl, 10 mM β-
mercaptoethanol and 1% (v/v) Thesit. Fractions were collected from the bottom to top. Molecular 
weight estimation was done by loading single protein markers on the sucrose gradient in same 
condition. 
 
5.5.3 Homo oligomerization of Vti1p and its TMD mutants 
Vti1p is a Q-SNARE protein. The two mutants Vti1p∆TMD (amino acid residues 1–
189), lacking the full TMD and Vti1pAla21, in which the TMD is replaced by oligo 
alanine (amino acid residues 190–212) were produced. These mutants were created 
to study the self-interaction of Vti1p without TMD and with altered TMD sequence. 
Self-interaction of Vti1p and its TMD mutants were studied by sucrose gradient 
separation. The results obtained (Figure 28) show that Vti1p (29 kDa) and 
Vti1p∆TMD are present as dimer but with an equilibrium with monomeric form, 
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whereas for Vti1pAla23 the equilibrium seems to be shifted to the monomeric form. 
This result is suggesting that Vti1p homo oligomerization is not mediated by TMD. 
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Figure 28. Self-interaction of Vti1p and its TMD mutants. Vti1p analyzed in 15-60% linear sucrose 
gradient. Sucrose gradient was prepared in 25 mM HEPES, pH 7.6, 1 M NaCl, 10 mM β-
mercaptoethanol and 1% (v/v) Thesit. Fractions were collected from the bottom to top. Molecular 
weight estimation was done by loading single protein markers on the sucrose gradient in same 
condition. 
 
5.5.4 Homo oligomerization of Vam7p 
Vam7p is a Q-SNARE protein. Vam7p does not contain any TMD. It is attached to 
membrane by N-terminal PX-domain, which is bound to phosphatidylinositol 3-
phosphate. In Figure 29 sucrose gradient separation of Vam7p (42 kDa) showed that 
it is mostly monomer.  
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Figure 29. Self-interaction of Vam7p. Vam7p analyzed in 15-60% linear sucrose gradient. Sucrose 
gradient was prepared in 25 mM HEPES pH 7.6, 1 M NaCl, 10 mM β-mercaptoethanol and 1% (v/v) 
Thesit. Fractions were collected from the bottom to top. Molecular weight estimation was done by 
loading single protein markers on the sucrose gradient in same condition. 
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5.5.5 Homo oligomerization of Ykt6p  
Ykt6p is an R-SNARE protein. Ykt6p was produced as GST-tagged or His6-tagged 
fusion protein. His6-tagged protein was produced for the CD experiment. Here, the 
self-interaction of these different Ykt6p fusion proteins was analyzed. Results 
obtained (Figure 30) show that in sucrose gradient separation GST-Ykt6p (48kDa) is 
mostly dimeric but in equilibrium with the monomeric form, while GST under same 
condition did not show any dimeric form. Sucrose gradient separation of His6-tagged 
Ykt6p showed mostly monomeric with some protein being distributed in all twelve 
fractions. This suggests that the homodimerization of GST-Ykt6 is due to weak 
interaction of Ykt6 while some unspecific aggregation in the absence of the soluble 
GST-tag.  
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Figure 30. Self-interaction of Ykt6p. A GST-Ykt6p and His-ykt6 analyzed in 15-60% linear sucrose 
gradient. Sucrose gradient was prepared in 25 mM HEPES, pH 7.6, 1 M NaCl, 10 mM β-
mercaptoethanol and 1% (v/v) Thesit. Fractions were collected from the bottom to top. Molecular 
weight estimation was done by loading single protein markers on the sucrose gradient in same 
condition. 
 
5.5.6 Assessment of self-interaction of SNARE proteins 
In summary the results obtained for self-interaction of SNARE proteins are presented 
in Table 7. In particular synaptobrevin II, a neuronal SNARE protein, is forming a 
dimer that is better preserved in urea SDS-PAGE than in SDS-PAGE in mild 
condition. The vacuolar Q-SNARE protein, Vam3p forms a dimer that is dependent 
on its TMD. Nyv1p and Vti1p dimers are not mediated by their TMD, but in case of 
Nyv1pAla21 and Vti1pAla23 mutants the equilibrium is shifted towards monomer 
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form. Vam7p is only monomer form, while in case of Ykt6p the protein is mostly in 
dimeric form. 
 
Table 7 Summary of self-interaction of SNARE proteins 
 
Protein Monomer Dimer Aggregation 
Synaptobrevin II +++ ++  
Vam3p + ++++ + 
Vam3p∆TMD ++++ + + 
Vam3pA4 ++++ + + 
Vam3pA4bb +++ ++ + 
Vam3pC274A + ++++ + 
Vam3pAla20 +++ ++ + 
Nyv1p +++ ++  
Nyv1p∆TMD +++ ++  
Nyv1pAla21 +++ +  
Vti1p ++ +++  
Vti1p∆TMD ++ ++  
vti1Ala23 +++ +  
Vam7p +++   
GST-Ykt6p ++ ++++  
His6-Ykt6p +++ ++ ++ 
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5.6 In vitro assembly of vacuolar SNARE complex 
Crucial step in membrane fusion is the formation of the SNARE complex, in which 
conserved regions, called ‘SNARE motif’ from the individual SNAREs associate and 
form a core complex (Hanson et al., 1995; Hay and Scheller, 1997), which consist of 
a parallel coiled coil. The neuronal SNARE complex is a heterotrimer of vesicular (R) 
SNARE synaptobrevin II and two plasma membrane (Q) SNAREs syntaxin 1A and 
SNAP-25. Later the crystal structure of the neuronal SNARE complex and 
endosomal SNARE complex was clarified and it was shown that three Q-SNARE 
proteins form a complex with one R-SNARE (Antonin et al., 2002; Sutton et al., 
1998).  
 
Here, in vitro SNARE complex assembly of yeast vacuolar SNARE proteins was 
studied. Previous studies show that alterations in the TMD clearly affected the 
stability of the cis-SNARE complex during the priming step and trans-SNARE pairing 
(Rohde et al., 2003). In the previous chapter, the self-interaction studies also showed 
that Vam3p homodimer is mediated by TMD, suggesting an important role of the 
TMD in vacuolar SNARE protein interaction. Different combinations of SNARE 
proteins and their mutants are studied here in vitro, in order to clarify the importance 
of their TMD in the yeast vacuolar SNARE protein assembly. 
5.6.1 In vitro SNARE complex assembly corresponding to trans-SNARE 
complex 
In yeast vacuolar fusion four SNARE proteins are involved in the last step of 
membrane fusion (Dietrich et al., 2004; Dietrich and Ungermann, 2004; Rohde et al., 
2003) – Vam3p, Nyv1p, Vam7p and Vti1p. Among these proteins, Nyv1p is an R-
SNARE and the rest are Q-SNAREs. The proteins were mixed together and 
incubated overnight. The mixture was gently pipetted onto the top of 15-60% linear 
sucrose gradient and it was centrifuged at high speed. Twelve fractions were 
collected from the bottom to the top and fractions were precipitated with TCA and 
analyzed by SDS-PAGE followed by Western blot with specific antibodies. Results 
are presented in Figure 31. For comparison panel A shows again self-interaction of 
the individual proteins (of Figure 26, 27, 28, 29). Panel B shows the result upon 
mixing the four SNARE proteins. In comparison with single protein separation on 
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sucrose gradient, some of the proteins (e.g. Nyv1p and Vti1p) are shifted towards 
higher molecular weight fractions (fraction 7–9) (Figure 31, panel B), whereas others 
behave similarly as in homomeric assembly (Vam3 and Vamp7). This result 
suggests some heterophilic interaction between Nyv1p/Vti1p proteins. In order to 
exclusively detect those proteins bound to Vam3p, each fraction of sucrose gradient 
was co-immunoprecipitated with rabbit anti-Vam3p antibody (Figure 31, panel C). As 
shown in Figure 31, panel C after co-immunoprecipitation it is possible to detect a 
complex, co-migrating with the 150 kDa marker, that may represent the quaternary 
SNARE complex (calculated molecular weight 141 kDa) (fraction 3–5). Other binary 
and ternary complexes appear to be present at lower molecular weight. 
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Figure 31. In vitro vacuolar SNARE complex assembly. SNARE complex assembly was analyzed 
by sucrose gradient. A 15-60% linear sucrose gradient was prepared with 25 mM HEPES pH 7.6, 1% 
(v/v) Thesit, 1 M NaCl, 10 mM β-mercaptoethanol. The fractions were collected from bottom to top 
and analyzed by SDS-PAGE and Western blot with specific antibodies. A, Individual protein (as 
reproduce from the Figure 26, 27, 28, 29) in sucrose gradient; B, SNARE protein mixture on sucrose 
gradient, C, fractions analyzed upon co-immunoprecipitation with rabbit anti-Vam3p.  
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5.6.2 Disassembly of SNARE complex  
Sec17p and Sec18p (Graham and Emr, 1991; Haas and Wickner, 1996; Hicke et al., 
1997; Mayer et al., 1996; Wickner, 2002) are α-SNAP and NSF homologs 
respectively. They are present in yeast to disrupt cis-SNARE protein complex, thus 
preparing the individual SNARE proteins for the formation of trans-SNARE 
complexes (see Figure 2, the “SNARE cycle” described in introduction). Here 
SNARE complex as identified by sucrose gradient and co-immunoprecipitation, was 
disassembled by Sec17p and Sec18p in presence of ATP (Horsnell et al., 2002; 
Sollner et al., 1993a). The SNARE protein overnight incubated mixture was 
incubated with recombinant Sec17p and Sec18p with MgCl2 and ATP or ATPγS for 
30 min at 4oC. The mixture was subjected to sucrose gradient, and analyzed as 
described in the previous section. The results (Figure 32, panel A & B) show that 
when SNARE protein mixture was incubated with Sec17p and Sec18p in presence of 
ATP, all proteins are localized at the monomeric position (Figure 32, panel A fraction 
9–12), but when the non-hydrolyzable ATPγS was used instead of ATP for control 
the SNARE protein assembly was not disrupted, as the proteins could be found in 
higher molecular weight fractions (Figure 32, panel B fraction 4-6), like the predicted 
SNARE complex shown in Figure 31, panel B. Therefore, the results obtained show 
that in vitro SNARE protein complex, as well as the homodimers, can be specifically 
disassembled by NSF and α-SNAP in presence of ATP and MgCl2. Thus the 
complex corresponds to a biologically relevant form rather than to an unspecific 
aggregate. 
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Figure 32. SNARE protein complex disassembly. SNARE complex assembly and disassembly 
were analyzed by sucrose gradient. A 15-60% linear sucrose gradient was prepared with 25 mM 
HEPES pH 7.6, 1% (v/v) Thesit, 1 M NaCl, 10 mM β-mercaptoethanol. The fractions were collected 
from bottom to top and analyzed by SDS-PAGE and Western blot with specific antibodies. A, SNARE 
protein mixture, incubated with Sec17p, Sec18p, ATP and MgCl2, B, SNARE protein mixture, 
incubated with Sec17p, Sec18p, ATPγS and MgCl2. 
 
5.6.3 SNARE complex assembly with Vam3p TMD mutants 
SNARE complex with Vam3p TMD mutants was also studied. It was shown in the 
previous section that Vam3p self-interaction is dependent on its TMD. The mutants, 
studied for Vam3p self-interaction, had previously been studied in in vitro vacuolar 
fusion assay ((Rohde et al., 2003) and J. Rohde and C. Ungermann, unpublished 
data). It has been shown that Vam3pA4 and Vam3p∆TMD fuse less efficiently than 
wild type, Vam3pA4bb fusion efficiency is similar to wild type (Rohde, 2002). The in 
vitro SNARE complex with Vam3p TMD mutants were analyzed by sucrose gradient 
separation followed by co-immunoprecipitation with rabbit Vam3p antibody and 
visualized by SDS-PAGE and Western blot with specific antibodies. The results 
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obtained are shown in Figure 33. Figure 33, panel A shows the in vitro SNARE 
complex with Vam3p∆TMD. Figure 33, panel B shows the SNARE complex 
formation with Vam3pA4. SNARE complex formation with Vam3pA4bb is shown in 
Figure 33, panel C, while the SNARE complex formation with Vam3pAla20 is 
presented in Figure 33, panel D. In comparison with wild type complex (Figure 31, 
panel C) Vam3p∆TMD and Vam3pAla20 are forming a SNARE complex (fractions 3-
5) with some higher oligomers (fractions 1-2) (Figure 33, panel A&D). The other 
mutants Vam3pA4 and Vam3pA4bb are not forming any higher oligomers (Figure 
33, panel B&D) but have a similar pattern like wild type complex of proteins (fraction 
3-5).  
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Figure 33. In vitro vacuolar SNARE complex assembly with Vam3pTMD mutants. SNARE 
complex assembly with Vam3p TMD mutants was analyzed by sucrose gradient. A 15-60% linear 
sucrose gradient was prepared with 25 mM HEPES pH 7.6, 1% (v/v) Thesit, 1 M NaCl, 10 mM β-
mercaptoethanol. The fractions were collected from bottom to top and co-immunoprecipitated with 
rabbit anti-Vam3p. The eluted proteins were then analyzed by SDS-PAGE and Western blot with 
specific antibodies. A, SNARE complex with Vam3p∆TMD; B, SNARE complex with Vam3pA4; C, 
SNARE complex with Vam3pA4bb; D, SNARE complex with Vam3pAla20. 
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5.6.4 SNARE complex assembly with cytoplasmic part of the SNARE 
proteins 
The yeast vacuolar SNARE proteins, Vam3p, Vti1p and Nyv1p, were also expressed 
without TMD (as ∆TMD), but containing the full SNARE cytosolic domain. Since 
Vam7p is without TMD, the wild type protein was used. The in vitro assembly of 
these mutant SNARE proteins was studied with sucrose gradient separation, 
followed by co-immunoprecipitation with rabbit anti Vam3p and visualized by SDS-
PAGE and Western blot with specific antibodies as described earlier. The results 
obtained are shown in Figure 34. Individual proteins on sucrose gradient are shown 
in Figure 34, panel A and in comparison the SNARE complex, as co-
immunoprecipitated with Vam3p, is shown in Figure 34, panel B. The individual 
∆TMD mutants are mostly monomeric or in equilibrium of monomers and dimers 
(Figure 34, panel A). When these proteins were mixed for complex formation, most 
of the proteins were shifted to higher molecular weight fractions (Figure 34, panel B 
fractions 1-5), thus suggesting SNARE complex formation (fraction 3-5) of the 
mutants containing only the cytoplasmic domains whereas supernatant after co-
immunoprecipitation indicates that the major parts of SNARE proteins (Vam7p, 
Nyv1p∆TMD and Vti1p∆TMD) are not bound with Vam3p∆TMD (Figure 34, panel C). 
In conclusion, deletion of TMD does not prevent formation of the SNARE complex. 
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Figure 34. In vitro vacuolar SNARE complex assembly with cytoplasmic domains. SNARE 
complex assembly with ∆TMD mutants was analyzed by sucrose gradient. A 15-60% linear sucrose 
gradient was prepared with 25 mM HEPES pH 7.6, 1% (v/v) Thesit, 1 M NaCl, 10 mM β-
mercaptoethanol. The fractions were collected from bottom to top and analyzed by SDS-PAGE and 
Western blot with specific antibodies. A, individual ∆TMD protein in sucrose gradient (reproduced 
from Figure 26, 27, 28, 29); B, co-immunoprecipitation of sucrose gradient fractions with rabbit anti-
Vam3p; C, supernatant after co-immunoprecipitation with rabbit anti-Vam3p.  
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5.6.5 SNARE complex assembly with alanine TMD mutants of the SNARE 
proteins 
The mutants of Vam3p, Vti1p and Nyv1p, in which the TMD was replaced by oligo 
alanine, were used for in vitro SNARE complex assembly. Since Vam7p does not 
contain TMD, the wild type Vam7p was used for complex formation. Therefore, all 
the proteins contain an intact SNARE domain and N-terminal domain, while the C-
terminal TMD is changed to alanine stretch. All the mutant proteins were mixed and 
incubated overnight at 4oC. The protein mixture was subjected to sucrose gradient 
centrifugation. Twelve fractions were collected from the bottom to top, individually 
co-immunoprecipitated with rabbit anti-Vam3p and analyzed on SDS-PAGE and 
Western blot with specific antibodies (Figure 35). Figure 35, panel A shows that the 
individual alanine mutants after sucrose gradient separation are mainly in monomeric 
form. Figure 35, panel B shows the SNARE complex with alanine TMD mutants. In 
comparison with the individual mutant proteins, the protein mixture shows a shift to 
higher molecular weight fractions (fraction 1–5) for all the mutant proteins except for 
Vam7p, which is detected only in the fraction 6-9, indicating that probably Vam7p is 
forming a binary complex with Vam3p as major part of Vam7p is detected in the 
supernatant after co-immunoprecipitation with anti-Vam3p (Figure 35, panel C). In 
the presence of TMD alanine mutant proteins a full SNARE complex is not detected, 
probably less specific interactions are occurring between Nyv1p, Vam3p and Vti1p 
mutants. 
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Figure 35. In vitro vacuolar SNARE complex assembly with alanine mutants. SNARE complex 
with alanine TMD mutants was analyzed by sucrose gradient. A 15-60% linear sucrose gradient was 
prepared with 25 mM HEPES pH 7.6, 1% (v/v) Thesit, 1 M NaCl, 10 mM β-mercaptoethanol. The 
fractions were collected from bottom to top and analyzed by SDS-PAGE and Western blot with 
specific antibodies. A, individual alanine TMD proteins in sucrose gradient (reproduced from Figure 
26, 27, 28, 29); B, co-immunoprecipitation of sucrose gradient fractions with rabbit anti-Vam3p; C, 
supernatant after co-immunoprecipitation with anti-Vam3p.  
 
5.6.6 SNARE complex assembly corresponding to cis-SNARE complex  
In yeast vacuole a pentameric cis-SNARE complex formed by Vam3p, Nyv1p, Vti1p, 
Vam7p and Ykt6p has been described (Ungermann et al., 1999a). For this 
pentameric complex assembly Ykt6p was used as GST fusion protein. The proteins 
were mixed together and incubated overnight at 4oC and then subjected to sucrose 
gradient separation. Twelve fractions were collected from the bottom to top. The 
fractions were analyzed by SDS-PAGE and Western blot with specific antibodies 
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(Figure 36). In Figure 36, panel A, the separation of the individual proteins shows 
that Ykt6p, Vam3p, Vti1p and Nyv1p are detected as monomer and dimer form, 
while Vam7p is mainly monomeric. Figure 36, panel B shows the separation of the 
SNARE complex assembly with all the five SNARE proteins on sucrose gradient. In 
comparison with the single proteins, the four proteins Vam3p, Nyv1p, Vti1p and 
Vam7p are detected in higher molecular weight fractions (fraction 4–6), but not 
Ykt6p, thus indicating that Ykt6p is not a part of full SNARE complex. Probably the 
more stabilized homodimeric form of GST-Ykt6p (as found in Figure 30) does not 
allow it to form complex. A more sensitive detection by co-immunoprecipitation was 
not possible because GST-Ykt6p is recognized by all antibodies against SNARE 
proteins. 
 
Vam3p
1 2 3 4 5 6 7 8 9 10 11 12
TopBottom
Vam7p
Nyv1p
Vti1p
GST-Ykt6p
1 2 3 4 5 6 7 8 9 10 11 12
Vam3p
Vam7p
Nyv1p
Vti1p
GST-Ykt6p
MW
kDa
2966150
A
B
SNARE
complex
binary or ternary
complex  
 
 
Figure 36. In vitro vacuolar SNARE complex assembly corresponding to cis-SNARE complex. 
SNARE complex assembly was analyzed by sucrose gradient. A 15-60% linear sucrose gradient was 
prepared with 25 mM HEPES pH 7.6, 1% (v/v) Thesit, 1 M NaCl, 10 mM β-mercaptoethanol. The 
fractions were collected from bottom to top and analyzed by SDS-PAGE and Western blot with 
specific antiobodies. A, individual proteins in sucrose gradient (reproduced from Figure 25, 26, 27, 28, 
29, 30); B, SNARE protein mixture on sucrose gradient. 
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6 Discussion 
The aim of this study was to investigate the role of TMD in SNARE protein 
interactions in vitro. In the first part, self-interaction of neuronal SNARE protein 
synaptobrevin II is discussed and in the second part the interaction of yeast vacuolar 
SNARE proteins is commented. 
6.1 Self-interaction of synaptobrevin II 
Synaptobrevin II is a v-SNARE or R-SNARE protein, localized in synaptic vesicles. 
Previous studies from our laboratory showed that synaptobrevin II has two 
interaction domains, cytosolic domain and C-terminal transmembrane domain 
(TMD). The TMD is important for synaptobrevin homodimerization (Laage and 
Langosch, 1997), as well as for heterophilic interaction with syntaxin 1A, whereas 
the cytosolic domain is important only for heterophilic interaction (Laage et al., 2000; 
Margittai et al., 1999). Here, homodimerization of synaptobrevin II was carefully re-
examined by two different methods: “mild” SDS-PAGE and “urea” SDS-PAGE. The 
aim was to pinpoint the effect of urea, previously used in interaction analysis (Laage 
and Langosch, 1997; Laage et al., 2000). “Mild” SDS-PAGE was done according to 
the method described by Bowen et al. (Bowen et al., 2002). Results obtained here 
(Figure 25) show that by mild SDS-PAGE only small amount of synaptobrevin II 
homodimer can be detected. On the contrary, significant amount of dimer is detected 
by urea SDS-PAGE (Figure 25) (Roy et al., 2004). In our experimental conditions 
urea can thus preserve the homodimerized form of synaptobrevin II. Generally urea 
is used to unfold proteins, though the mechanism is still unknown. According to one 
hypothesis, urea disorder the water structure around the hydrophobic domains of 
unfolded proteins, thus weakening the strength of the hydrophobic effect in protein 
folding (Dill and Shortle, 1991). Here, the secondary structure analysis of 
synaptobrevin II TMD peptide revealed similar helical content in detergent solution 
with and without 6 M urea (Table 2). This demonstrates that urea does not denature 
this helix and suggests specificity of this protein-protein interaction since urea is also 
known to suppress unspecific aggregation of membrane proteins in SDS-PAGE 
(Soulie et al., 1996). Possibly urea is required to fully denature the nuclease fusion 
domain (Flanagan et al., 1992; From and Bowler, 1998) in this construct, since low-
level of dimerization can also be seen in the absence of urea when the nuclease 
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fusion domain is missing (Bowen et al., 2002; Margittai et al., 1999) or proteolytically 
cleaved (Laage and Langosch, 2001). In addition to that, urea is known to affect the 
behavior of detergents by increasing the water solubility of its acyl moieties (Walter 
et al., 2000) and might thus induce formation of larger and less tightly packed 
micelles.  
 
Homodimerization of native synaptobrevin II was also observed when it is cross-
linked with DSS and iodine in isolated synaptic vesicles (Roy et al., 2004). DSS, 
which primarily reacts with lysine side chains localized within the soluble part of the 
proteins, showed that synaptobrevin II forms heterodimers with synaptophysin along 
with homodimer but no cross-linked products were detected with syntaxin 1A or 
SNAP-25 (Calakos and Scheller, 1994; Edelmann et al., 1995; Washbourne et al., 
1995). On the contrary, iodine leads to intermolecular disulfide bridge formation of 
the whole protein, that is, to cysteine 103 within the TMD (Figure 20, sequence of 
synaptobrevin II TMD sequence). Since disulfide formation requires spatial proximity 
of cysteines, the detection of iodine cross-linked synaptobrevin II homodimers 
suggested that homodimerization in synaptic vesicles involves TMD–TMD interface 
(Laage and Langosch, 1997; Laage et al., 2000). This agrees well with the model 
computed by Fleming and Engelman (Fleming and Engelman, 2001) where cysteine 
103 represents the site of closest contact within the TMD–TMD interface. 
Accordingly, the cross-linkable synaptobrevin molecules must contain an unmodified 
cysteine residue. Nevertheless, the intriguing possibility remains that part of native 
synaptobrevin is palmitoylated at cysteine 103, as found by Veit et al., although it 
could not be acylated in synaptic vesicles from embryonic brain (Veit et al., 2000) 
and therefore it could not form homodimer via TMD–TMD interaction when it is 
acylated. One may therefore speculate that synaptobrevin II homodimerization in 
vivo is regulated by this covalent modification that is known to be reversible and 
frequently regulated in a highly specific way (Veit et al., 2000; Veit et al., 2001).  
 
Synaptobrevin II TMD–TMD self-assembly was further shown by ToxR assay (Roy et 
al., 2004). The degrees of interaction were comparable to that of membrane-
spanning leucine zipper (Gurezka et al., 1999) and lower than the glycophorin A 
TMD (Brosig and Langosch, 1998; Langosch et al., 1996). Glycophorin A adopts a 
negative packing angle as indicated by mutagenesis (Laage and Langosch, 1997; 
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Laage et al., 2000; Langosch et al., 1996; Lemmon et al., 1992; Mingarro et al., 
1996), model building (Adams et al., 1996; Fleming and Engelman, 2001) and NMR 
spectroscopy (MacKenzie et al., 1997; Smith et al., 2001) and its TMD interface 
harbors a critical GxxxG motif. This motif is thought to drive TMD–TMD packing by 
formation of a flat helix surface, by limiting entropy loss that is normally associated 
with the freezing of side chain conformations upon protein-protein interaction (Russ 
and Engelman, 2000), or by facilitating hydrogen bond formation between Cα-
hydrogens and the backbone of the partner helix (Senes et al., 2001) or by a 
combination of these. It is not surprising, therefore, that the synaptobrevin II TMD 
self-interacts with a lower affinity than that of glycophorin A (Roy et al., 2004). 
 
Thus, synaptobrevin appears to exist in different forms – that is, as a monomer, as a 
homodimer, or bound to synaptophysin or to other SNAREs – at the various stages 
of the synaptic vesicle cycle. Synaptobrevin II TMD–TMD self-assembly may have to 
be of sufficiently low affinity to allow for rapid interconversion of these complexes 
during neurotransmitter release (Roy et al., 2004). 
6.2 Self-interaction of vacuolar SNARE proteins 
Five SNARE proteins were found in yeast vacuole (Darsow et al., 1997; Nichols et 
al., 1997; Ungermann et al., 1998a; Ungermann et al., 1998b; Ungermann et al., 
1999a) – Vam3p, Nyv1p, Vam7p, Vti1p and Ykt6p, where Vam3p, Vam7p and Vti1p 
are Q-SNAREs and Nyv1p and Ykt6p are R-SNAREs (Darsow et al., 1997; Dilcher 
et al., 2001; Fischer von Mollard and Stevens, 1999; Fischer von Mollard et al., 
1997; Kweon et al., 2003; Nichols et al., 1997; Sato et al., 1998; Wickner and Haas, 
2000). Among them Vam3p, Nyv1p and Vti1p contain a C-terminal TMD, while 
Vam7p and Ykt6p do not contain a TMD. Ykt6p is attached to the membrane via 
prenyl-anchor at the C-terminal (McNew et al., 1997) and Vam7p via an N-terminus 
PX-domain, which interacts with phosphatidylinositol 3-phosphate (Boeddinghaus et 
al., 2002). Rohde et al. observed that replacement of TMD from Vam3p by an 
isoprenoid anchor causes poor vacuole fusion. This functional defect was associated 
with stabilization of the cis-complex, since an extra amount of Sec18p was required 
to disrupt it and to release the individual SNARE proteins. Surprisingly, a higher 
amount of trans-complex was detected in cells expressing this Vam3p mutant 
compared to the wild type. Further, when the cytosolic SNARE motif is mutated in 
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Vam3p, the mutant did not show vacuolar fusion due to lack of trans-SNARE pairing. 
In contrast, isoprenoid mutant of Vam3p showed trans-complex formation but was 
deficient in fusion. These results indicate that Vam3p TMD is crucial at a stage of 
membrane fusion after trans-SNARE pairing (Rohde et al., 2003). Moreover 
mutations in the TMD of Vam3p are affecting vacuole fusion to a greater degree 
when they affect one helix interface (i.e. Vam3pA4), compared to mutations at the 
opposite side (i.e.Vam3pA4bb) (Rohde, 2002).  
 
Here, we characterized homophilic interactions of all recombinantly expressed yeast 
vacuolar SNARE proteins by sucrose gradient to assess the role of the TMD. Self-
interaction studies of Vam3p and its mutants show (Figure 26) that Vam3p wild type 
is mainly in dimer form, whereas the deletion of TMD (Vam3p∆TMD) or its mutation 
(Vam3pA4 and Vam3pA4bb) causes a shift towards the monomeric form. The 
homodimerization of Vam3p is not mediated by the cysteine at 274, as the 
Vam3pC274A mutant showed a dimeric form in sucrose gradient similar to wild type 
Vam3p. The deletion of TMD of Vam3p or mutation in TMD did not change the 
secondary structure of the Vam3p full length protein (Table 3). For a detailed 
characterization, also the corresponding TMD peptides were analysed via CD 
spectroscopy. The wild type Vam3pTMD peptide is highly α-helical in TFE (~80%) as 
well as in detergent solution (59%). Also the Vam3pA4 TMD peptide shows highly α-
helical secondary structure in TFE (~80%) as well as in detergent solution (68%) 
(Table 3). Strikingly the full length Vam3pA4 protein in sucrose gradient is in 
monomeric form (Figure 26), suggesting that sequence specific interaction of TMD is 
required for dimers. The TMD peptide of Vam3pA4bb is less α-helical (39%) than 
that of wild type or Vam3pA4 and its β-sheet content is increased to 14% (Table 3). 
This structural perturbation may be due to the mutation of two leucines into alanines 
(Figure 14), as leucine is known to stabilize α-helical structure (Hofmann et al., 2004; 
Minor and Kim, 1994; Street and Mayo, 1999). The mutant protein Vam3pA4bb is 
distributed between monomeric and dimeric forms in sucrose gradient probably 
because the helical nature of TMD is compromised severely. The TMD of Vam3p 
was also substituted by 20 alanines and this mutant protein in sucrose gradient 
shows a monomeric and dimeric distribution (Figure 26). This dimer may be due to 
the weak interaction of the 20 alanine repeat although it was found previously that 16 
alanine gives very weak interaction (Gurezka et al., 1999). In summary, results 
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showed that Vam3p is mainly in dimeric form by sucrose gradient analysis and 
mutations or deletion of the TMD can disrupt its self-interaction, thus supporting that 
Vam3p dimer formation is mediated by the TMD. Vam3p, a syntaxin analog in yeast 
vacuole, has therefore two interaction domains: SNARE domain and C-terminal 
TMD, like syntaxin 1A and synaptobrevin II. 
 
Similarly, the self-interactions of other SNARE proteins were studied by sucrose 
gradient. Results obtained show that Nyv1p and Nyv1p∆TMD are mainly monomeric 
and possibly in equilibrium with small amounts of dimeric forms, while in case of 
Nyv1pAla21 the protein exists only in monomeric form (Figure 27). In sucrose 
gradient separation Vti1p and Vti1p∆TMD are mainly in dimeric form, while 
Vti1pAla23 is mainly in monomeric form (Figure 28). Therefore in case of Vti1p and 
Nyv1p the dimerization seems not to be mediated by the TMD of these proteins but 
probably by the SNARE domain. A recent study with Vti1p revealed that homo-
oligomerization of the cytoplasmic domain produced hexamers or higher molecular 
weight oligomer depending on the glycerol (0–15 %) and salt (0–200 mM NaCl) 
concentration of the buffer (pH 5.6–8). It seems that oligomerization of Vti1p 
cytoplasmic domain may be favored under dehydrating conditions and by the 
electrostatic effect (Tishgarten et al., 1999). Here, in the presented experimental 
condition (25 mM HEPES, pH 7.6, 1 M NaCl, 10% glycerol) higher molecular weight 
oligomers of full length Vti1p were also observed with different detergents (Triton X-
100 and CHAPS as shown in Table 1) in sucrose gradient. It was mentioned earlier 
that full length Vti1p could not be stabilized in solution less than 1 M NaCl, thus the 
other mutants of Vti1p were solubilized in 1 M NaCl. Moreover Tishgarten et al. 
found 76% α-helical content of Vti1p∆TMD at higher concentration of protein 
(Tishgarten et al., 1999) and a little less than the result obtained here (84% α-helical, 
Table 5). It could be, therefore, possible that the higher oligomers obtained by 
Tishgarten et al. are due to unspecific aggregation. However, the decreased 
amounts of dimeric form of Nyv1pAla21 and Vti1pAla23 remain unclear. Structural 
analysis showed the wild type as well as the alanine mutants have similar secondary 
structures (Table 4 & 5). Probably the dimerization of Nyv1p and Vti1p is mediated 
by SNARE domain, which is somehow perturbed in these alanine repeat mutants.  
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Self-interactions of Vam7p and Ykt6p were also examined by sucrose gradient. In 
particular Vam7p is monomeric (Figure 29), while ykt6 GST fusion protein is mainly 
in dimeric form even with a certain amount of monomeric form (Figure 30). As 
control, the GST protein itself did not show any dimeric form in this condition. 
Probably GST-Ykt6p fusion protein dimerizes due to weak self-affinity of Ykt6p 
supported by weak GST dimerization. However Ykt6p without any soluble fusion 
protein (His6-Ykt6p) formed monomer plus unspecific aggregates (Figure 30). 
Structural analysis of Ykt6p showed less α-helical and more β-sheet content 
compared to other SNARE partners (Table 6). Crystal structure of the N-terminus of 
Ykt6p revealed five β-sheet strands, which are sandwiched by one α-helix on one 
side and two α-helices on the other side (Dietrich et al., 2003; Tochio et al., 2001). In 
summary, Vam3p dimerization is mediated by TMD and Vti1p dimer seems not to be 
dependent on TMD whereas Nyv1p is mainly monomer with a small amount of dimer 
and that is not affected upon deletion of TMD. The other SNARE protein Vam7p 
shows monomer and GST-Ykt6p is dimer in sucrose gradient.  
6.3 SNARE complex assembly 
In yeast vacuole fusion the trans-SNARE complex forms during the docking step, 
which is the second step before membrane fusion. Insights into trans-SNARE 
complex formation can help in understanding how SNARE protein interactions lead 
to membrane fusion. In vacuolar membrane fusion only four proteins are 
participating in the trans-SNARE complex – Vam3p, Nyv1p, Vam7p and Vti1p 
(Dietrich et al., 2004; Rohde, 2002; Rohde et al., 2003) following the general 
stoichiometry rule for SNARE complex formation: three Q-SNARE proteins and one 
R-SNARE protein. Here, all four vacuolar SNARE proteins were mixed to detect, 
after sucrose gradient separation, formation of a high molecular weight complex 
indicative of the formation of the tetrameric SNARE complex (Figure 31). To 
separate Vam3p associated proteins from free SNAREs, each fraction of sucrose 
gradient was first co-immunoprecipitated with anti-Vam3p antibody and reprobed 
with all the other specific antibodies in a Western blot. Results obtained (Figure 31) 
show that part of all four proteins co-migrated at a molecular weight of 150 kDa after 
co-immunoprecipitation, showing the partial formation of the full SNARE complex 
(fraction 3-5). Other intermediate complexes like binary or ternary complexes with 
Vam3p, [e.g. interaction of Vam3p and Vam7p or Vam3p with other SNARE proteins] 
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are also detected. As shown in Figure 32, in the presence of Sec18p, Sec17p and 
ATP the SNARE complex is completely disassembled (Figure 32), indicating that the 
complexes are not representing unspecific aggregation of the SNARE proteins.  
 
Previous results obtained with in vitro fusion assay showed that Vam3p TMD is 
important for vacuolar membrane fusion (Rohde, 2002; Rohde et al., 2003), since 
TMD deletion leads to a significant decrease in fusion efficiency. In vitro analysis of 
the different SNARE complexes containing mutants with deleted or mutated TMDs is 
a good strategy for understanding the involvement of TMD in SNARE protein-protein 
interactions. In this study, in vitro SNARE complex assembly with Vam3p mutants 
plus the other wild type SNARE proteins shows that both complexes containing 
Vam3p∆TMD and Vam3pAla20 are forming higher molecular weight multimers in 
addition to the complexes seen in wild type (Figure 33), suggesting partial loss in 
specificity of protein-protein interactions. The formation of these oligomers may 
account for the described accumulation of the mutant trans-SNARE complex upon 
docking in vitro of respective yeast vacuole (Rohde et al., 2003). Vam3pA4 mutant, 
in which four amino acids were mutated into alanine, showed less fusion efficiency in 
in vitro fusion assay (unpublished). Sucrose gradient result shows that Vam3pA4 has 
a similar SNARE complex assembly as wild type (Figure 33, fraction 4-5). On the 
other hand when the alanine mutation (Vam3pA4bb) was carried out on the backside 
of the helix, in in vitro fusion assay the fusion efficiency was between wild type and 
Vam3pA4. Here sucrose gradient result shows that Vam3A4bb forms a similar 
SNARE complex (Figure 33) like wild type or A4 mutant. Probably these mutants are 
affecting membrane fusion after post docking stage like Vam3p isoprenoid mutant 
(Rohde et al., 2003). 
 
Considering all the result of the self-interaction and the ternary complex formation 
with different Vam3p TMD mutants of yeast vacuolar SNARE proteins the possible 
interactions cycle could be summarized as (Figure 37) – i) Vam3p and Vti1p are 
stabilized as dimer, ii) Vam3p is in binary or ternary complex with other SNARE 
proteins as intermediate complexes, iii) SNARE proteins form tetrameric full complex 
which is completely zipped till TMD.   
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Figure 37. Possible interaction cycle of yeast vacuolar SNARE proteins. The individual yeast 
vacuolar SNARE proteins are present in monomeric forms that are in equilibrium with dimeric (homo- 
or hetero-dimers) forms and ternary forms. The monomeric vacuolar SNARE proteins and the 
intermediate complexes are also in equilibrium with the full tetrameric vacuolar SNARE complex. 
Unspecific multimers are not considered in this picture. 
 
SNARE complex formation was also studied with the only cytoplasmic domains of all 
the SNARE proteins. Co-immunoprecipitation results show the formation of 
multimeric aggregates of SNARE complexes in addition to smaller complexes 
(Figure 34). This result confirm the possibility of SNARE complex formation via 
SNARE motif without the C-terminal TMD as found by other investigators (Fasshauer 
et al., 1999; Yang et al., 1999).  
 
SNARE complex was assembled also with vacuolar SNARE protein mutants, in 
which the TMD had been substituted by alanine repeats. The results obtained here 
by sucrose gradient separation show that Vam3pAla20, Nyv1pAla21 and Vti1pAla23 
interact to form complexes, but a full SNARE complex with all the four proteins can 
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not be detected as Vam7p is not found in fraction 3-5 (Figure 35), whereas most of 
the Vam7p was detected in the supernatant of the immunoprecipitated fractions. 
 
Since a pentameric cis-complex, made by Vam3p, Nyv1p, Vti1p, Vam7p and Ykt6p, 
was described in yeast vacuole (Ungermann et al., 1999a) I incubated all these five 
SNAREs for in vitro complex formation. The sucrose gradient separation of the 
mixture of five SNARE proteins shows that Ykt6p is not detected in the high 
molecular weight fractions, as the other four proteins (fraction 3-5) (Figure 36), 
indicating the formation of SNARE complex without Ykt6p. A more sensible detection 
by co-immunoprecipitation was not achievable because GST-Ykt6p is recognized by 
all the antibodies used. In our experimental conditions it was not possible to detect a 
pentameric complex, possibly due to: i) the very unstable Ykt6p interaction with other 
SNARE proteins, or ii) the stabilization of dimeric form in GST-Ykt6p, or iii) the 
autoinhibitory effect of Ykt6p N-terminus domain (Tochio et al., 2001). It has been 
shown that Ykt6p is responsible of Vac8p palmitoylation and it is released during the 
priming step of vacuole fusion, when cis-complex is disrupted (Dietrich et al., 2004). 
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7 Conclusions 
In summary, it can be concluded from the work presented here that synaptobrevin II 
homodimerization was successfully detected by urea SDS-PAGE and urea is not 
hampering the secondary structure of the synaptobrevin II TMD. 
 
Studies on yeast vacuolar SNARE proteins showed that Vam3p self-interaction is 
mediated by the TMD. Mutations in Vam3p TMD or deletion of the Vam3p TMD 
disrupt the Vam3p homo interaction. The other yeast vacuolar SNARE proteins: 
Nyv1p and Vti1p form homo dimers, but they are not mediated by their TMD. 
Probably the homo dimers of Nyv1p and Vti1p are mediated by the SNARE domain 
of these proteins. Also soluble Ykt6p shows homo dimer in sucrose gradient 
separation. The other vacuolar SNARE Vam7p is monomer in native condition. 
 
Results obtained here show for the first time the isolation of an in vitro complex of 
the full length vacuolar SNARE proteins – Vam3p, Nyv1p, Vti1p and Vam7p. SNARE 
complex can be disrupted by Sec18p and Sec17p in the presence of ATP and 
MgCl2, confirming that it is a specific SNARE complex and not an unspecific 
aggregation of the proteins. Vam3p TMD has a key role in SNARE complex, since its 
exchange or deletion is strongly affecting SNARE complex assembly, leading to the 
partial formation of probably unspecific multimeric complexes. Deletion of all the 
TMDs of SNARE proteins or their mutations into alanine stretch leads to the 
formation of same unspecific multimeric complexes. In our experimental condition a 
pentameric SNARE complex with Vam3p, Nyv1p, Vti1p, Vam7p and Ykt6p could not 
be identified, but other binary or ternary interactions of Ykt6p with other SNARE 
proteins can not be ruled out.  
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8 Future outlooks 
The results presented here showed the importance of vacuolar SNARE proteins 
TMD in their homo interactions and complex formation, though several aspects need 
to be addressed to elucidate a more precise picture of the SNARE complex and 
membrane fusion. Results presented here showed that Vam3p TMD is important for 
self-interaction and SNARE protein interaction and membrane fusion. Alanine 
scanning mutagenesis can be carried out to reveal the important amino acids for 
Vam3p TMD-TMD interaction. The binary and ternary interactions of SNARE 
proteins can reveal more insight about the composition of cis-SNARE complexes 
and the importance of TMD in the SNARE proteins interactions. Mutations in the 
other part of the SNARE proteins also can be carried out to know the importance in 
mediating interaction.   
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10 Abbreviations 
 
A     Ala    Alanine 
C     Cys    Cysteine 
D     Asp    Aspartate 
E     Glu    Glutamine 
F     Phe    Phenylalanine 
G     Gly    Glycine 
H     His    Histidine 
I     Ile    Isoleucine 
K     Lys    Lysine 
L     Leu    Leucine 
M     Met    Methionine 
N     Asn    Asparagine 
P     Pro    Proline 
Q     Gln    Glutamine 
R     Arg    Arginine 
S     Ser    Serine 
T     Thr    Threonine 
V     Val    Valine 
W     Trp    Tryptophane 
Y     Tyr    Tyrosine 
  
 
 Amp  Ampicillin 
 APS  Ammonium persulfate 
 BSA  Bovine serum albumin 
 CD  Circular dichroism 
 C.elegans Caenorhabditis elegans 
CHAPS 3-3[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonate 
Cm  Chloramphenicol 
Da  Dalton 
DMP  Dimethylepimilidate 
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DMSO Dimethylesulfoxide 
DNA  Deoxyribonucleic acid 
DNase Deoxyribonuclease 
dNTP  deoxynucleoside (5’-) triphosphate 
ddNTP di deoxynucleoside (5’-) triphosphate 
ds DNA double strand DNA 
DTT  1,4-dithiothretol 
E.coli  Escherichia coli 
EDTA  Ethylenediamine-N-N-N’-N’-tetraacetic acid 
EtOH  Ethanol 
g  Acceleration of free fall (9.81 m/sec2)  
GST  Glutathione S-transferase 
hr  Hour 
HA  Hemagglutinin 
HEPES 4-2(2-hydroxy-ethyl)-1-piperzine-ethanesulfonic acid 
His-tag Hexa-histidine sequence 
HRP  Horseradish peroxidase 
kDa  kilodalton 
l  Liter 
LB  Luria-Broth 
M  Molar 
mA  Miliampete 
MeOH  Methanol 
mg  Miligram 
min  Minute 
ml  Mililiter 
mM  Milimolar 
nm  nanometer (10-9 m) 
NSF  N-ethylmaleimide sensitive factor 
OD  Optical density (absorbance) 
PBS  Phosphate buffered saline 
PCR  Polymerase chain reaction 
PMSF  Phenylmethylsulfonyl fluoride 
RNA  Ribonucleic acid 
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SDS  Sodium dodecyle sulfate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
sec  Second 
SNAP  Soluble N-ethylmaleimide sensitive factor attachment protein 
SNAP-25 Synaptosomal associated protein of 25 kDa 
SNARE Soluble NSF attachment protein receptor 
TBB  TBS with 0.1% Triton-X 100 and 5% milk powder 
TBS  Tris-buffered saline 
TEMED N-N-N’-N’-tetra methylethylenediamide 
TMD  Transmembrane domain 
Tris  2-amino-2-hydroxymethyl-1,3-propanediol 
tRNA  Transfer RNA 
TWB  TBS with 0.1% Triton-X 100 
µl  Microliter (10-6 l) 
WT  Wild type  
